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ABSTRACT OF DISSERTATION
NOVEL COMPUTATIONAL METHODS FOR TRANSCRIPT
RECONSTRUCTION AND QUANTIFICATION USING RNA-SEQ DATA
The advent of RNA-seq technologies provides an unprecedented opportunity to pre-
cisely profile the mRNA transcriptome of a specific cell population. It helps reveal
the characteristics of the cell under the particular condition such as a disease. It
is now possible to discover mRNA transcripts not cataloged in existing database,
in addition to assessing the identities and quantities of the known transcripts in a
given sample or cell. However, the sequence reads obtained from an RNA-seq ex-
periment is only a short fragment of the original transcript. How to recapitulate the
mRNA transcriptome from short RNA-seq reads remains a challenging problem. We
have proposed two methods directly addressing this challenge. First, we developed a
novel method MultiSplice to accurately estimate the abundance of the well-annotated
transcripts. Driven by the desire of detecting novel isoforms, a max-flow-min-cost al-
gorithm named Astroid is designed for simultaneously discovering the presence and
quantities of all possible transcripts in the transcriptome. We further extend an ab
initio pipeline of transcriptome analysis to large-scale dataset which may contain
hundreds of samples. The effectiveness of proposed methods has been supported by
a series of simulation studies, and their application on real datasets suggesting a
promising opportunity in reconstructing mRNA transcriptome which is critical for
revealing variations among cells (e.g. disease vs. normal).
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Chapter 1 Introduction
Uncovering the mystery of the functioning and heredity of living organisms has been
and remains to be one central mission of the life sciences. Human genetics, the
study of genes, heredity, and variation of human species, is of great interest. Genes
are basic functional units that determine an individuals’ unique traits. They not
only decide our hair color but also holds the information of the genetic traits pass-
ing to offspring. More specifically, the research of human genetics will help unveil
all fascinating mechanisms about human: i.e. how genetic inheritance or various
characteristics takes place from parents to kids, and therefore, is highly important.
One of the major milestones of the human genetics study was the effort of Human
Genome Project (HGP) which aims at identifying approximate all the 30, 000 genes in
human DNA. Upon its completion in 2003, over three billion human DNA bases have
been catalogued in the database, shedding lights on the study of human genetics.
Moreover, the study on human genome also led to a new era of “genomic medicine”
where genetics is playing a more and more important role in the diagnosis, prognosis,
and treatment of diseases that are caused by genetic abnormalities and mutations.
Before genomic medicine, most diseases were defined by clinical symptoms and treated
with one-fits-all treatments. This approach failed to account for individual biolog-
ical background. However, nowadays more and more diseases are being defined at
the molecular level, facilitating one’s unique genetic information being used to im-
prove health outcome. With the revolution of genome analysis, we are able to detect
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biomarkers distinguishing between normal and diseased cells. For example the ge-
netic characteristics responsible for tumor progression in breast cancer (e.g. HER2+
marker) could serve as potential drug responses and are very informative for precise
and personalized treatment. Furthermore, genetic factors can also help to assess the
risk of a particular disease in an individual. This is known as genetic tests. Once a
high risk is confirmed, continuous monitoring and preventive measures can be taken
to reduce the risk of that disease.
The great success of genetics in medical practice have stimulated the development
of sequencing technology which aims to determine the sequence of entire genome, indi-
vidual genes or other important molecules in a living organism. In a typical sequenc-
ing experiment, the bases of a small fragment of DNA are sequentially detected and
millions of such fragments are generated from target DNA. However, only knowing
the sequence is not enough, the real challenge lies in how to elucidate the connection
between sequence and the gene functions, and further find out the way genes are
related to phenotypes and diseases. In the past decade, many contributions have
been made to answer this question, but efficient and effective computational meth-
ods are still in emerging needs. Therefore, this dissertation is dedicated to develop
computational models to bridge the gap between raw sequencing data and biological
findings. In this chapter, we will briefly review the biological backgrounds, introduce
the problems we wish to address, and present an overview of our efforts.
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1.1 Biological background
Francis Crick, the Nobel Prize winner in Physiology or Medicine in 1962, has once
given a straightforward explanation of the flow of genetic information in a living
organism: “DNA makes RNA and RNA makes protein” (Figure 1.1). This statement
was then augmented into the central dogma of molecular biology as the following
“DNA makes RNA, RNA makes proteins, proteins make us”. Though a simplification,
this general rule sketches the connections of all important molecules and emphasizes
the order of the events in our body.
In this section, we will follow the central dogma, review the basic biological con-
cepts and then introduce the related sequencing technology platforms for analysis.
Figure 1.1: A figure illustrates the central dogma of molecular biology. Figure ac-
commodated from Wikepedia( www.wikepedia.com)
.
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1.1.1 The genome in living organisms
For all living organisms, cells serve as their basic building blocks. Take human body
for example, it is made of trillions of cells. They support structure for the body and
carry out specialized functions. Most importantly, they hold the hereditary material
instructing the development and functioning of the organism (Figure 1.2a). This
important information is stored in DNA (deoxyribonucleic acid). DNA is a molecule
with double stranded structure as shown in Figure 1.2b. It is composed of four
chemical bases: adenine (A), guanine (G), cytosine (C), and thymine (T). The order,
or sequence of these bases then determines the hereditary information. Human DNA
contains more than 3 billion bases.
(a) (b)
Figure 1.2: (a) In cells, nuclear DNA resides within the chromosomes. (b) DNA
is a double helix formed by base pairs attached to a sugar-phosphate backbone.
Figure accommodated from Wikepedia( www.wikepedia.com) and Genetics Home
Reference( www.ghr.nlm.nih.gov)
The genome refers to the entire set of unique DNA that makes up a particular
organism. On the genome, there are segments of sequences which serve as the basic
physical and functional unit of heredity. They are called genes. In humans, genes
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vary in size from a few hundred DNA bases to more than 2 million bases, and totally
less than 30,000 genes are identified. For all human beings, they share more than
99% similarity at the gene-level. But the small differences (less than 1% of genes)
contribute greatly to the diversity of people.
1.1.2 The mRNA transcripts and proteins
Proteins are very important molecules consisting of one or more chains amino acids.
Basically, every function in a living cell depends on proteins, from antibody and en-
zyme to structural component and transport/storage [Phizicky et al., 2003]. Since
proteins play very critical roles in a living organism, it is a long-term interest for
scientists pursuing the mechanism of protein activities and deciphering their rela-
tionship with the genes. The journey from gene to protein is complex. It consists of
two steps: transcription and translation (Figure 1.3).
Within a gene, the sequences that will code the final protein sequence are specified
in the unit of exons (functional parts), and the rest sequences are called the introns
(non-functional parts). In the process of transcription, introns are removed and the
exons are concatenated in an mRNA transcript, following the transcription order of
the gene. Each mRNA transcript then serves as a template for producing a protein.
On the mRNA transcript, every contiguous three bases, called a codon, code for one
particular amino acid. In the translation, the amino acids are assembled sequentially
from the start codon to the end codon and form a protein.
However, the process of transcription can be further complicated by the mecha-
nism of alternative splicing, through which different subsets of exons in a gene may be
5
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Figure 1.3: Genes and mRNA transcripts. Through alternative splicing, an important
regulation process, one gene may code for multiple mRNA transcripts. Here a gene
can be considered as a directed acyclic graph with vertices representing exons and
directed edges representing splice junctions (introns). Different sets of exons may be
retained to form different mRNA transcripts, for example, exons 1, 3, 4 and 5 form
isoform α and the other set of exons form isoform β. Alternative transcripts will
typically lead to different amino acid sequences. As a result, the produced proteins
will have different amino acid compositions and structures, hence varied functions.
concatenated to form different transcript isoforms [Sultan et al., 2008, Wang et al.,
2008a, Pan et al., 2008a, Kwan et al., 2008]. Unlike the genome which is mostly
fixed except for small changes such as mutations, the transcripts present and their
individual abundance may vary in response to time and environmental factors hence
may characterize the cell at a specific condition. See Figure 1.3. The analysis of the
mRNA transcriptome, which consists of mRNA transcripts that are transcribed from
the protein-coding genes then becomes a key to revealing the linkage from genotype
to phenotype [Adams, 2008, Wang et al., 2008a].
By studying the transcriptome, we could find out which transcript isoforms are
turned on and off in various cells or tissues (qualitative analysis). Also, the quanti-
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ties of the expressed transcript isoforms could be used for analyzing their behaviors
(quantitative analysis). Both studies are fundamental for downstream differential
expression and transcription analysis between normal and diseased cells which help
identify the biomarkers for potential drug target [Wang and Cooper, 2007]. Similarly,
they could provide insight into the changes of the transcriptome at various stages of
development [Wang et al., 2008a, Trapnell et al., 2010a].
1.1.3 Traditional approaches for transcriptome study
The traditional technique for studying the transcriptome is DNA Microarray technol-
ogy [Clark et al., 2002, Russo et al., 2003]. In a Microarray experiment, thousands of
spotted samples known as probes with known identity (pre-knowledge of sequences)
are immobilized on a solid support. The spots can be DNA, cDNA, or oligonu-
cleotides. These are used to determine complementary binding of the sequences thus
allowing parallel analysis for gene expression. Figure 1.4 illustrates the detailed pro-
cedure of the experiment. The sequences of interest is first purified, then PCR is used
for to amplify the sequences. The core principle behind microarrays is hybridization
between two DNA strands, the specific pairing of complementary nucleic acid se-
quences. A high number of complementary base pairs in a nucleotide sequence means
tighter non-covalent bonding between the two strands. A nucleic acid target is fluo-
rescently labeled, hybridized to the sequences, and washed after hybridization. The
abundance of the provided sequence is the strength of the signal which depends on
the amount of targets binding to the sequence [Wiki].
The Microarray has been used as a powerful tool to measure the expression levels
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of large number of genes simultaneously, which has empowered the full understanding
of human genome and transcriptome.
Figure 1.4: Microarray experiment steps. Figure accommodated from Wikepe-
dia( www.wikepedia.com)
Besides Microarray, there exist other techniques, like CAGE (Cap analysis gene
expression) [Shiraki et al., 2003] and SAGE (Serial analysis of gene expression) [Vel-
culescu et al., 1995] have also been developed to determine the transcription start
position and transcript expression, provided the transcript sequence. In the experi-
ments, the small fragments from the very beginnings (5’ ends of capped transcripts) or
the end (3’ ends of capped transcripts) of mRNAs are extracted, reverse-transcribed
to DNA, PCR amplified and sequenced. The expression level of the transcripts can
be estimated by the observed counts of the sequenced fragments.
All these technologies suffer from some limitations. For example, they all re-
quire the pre-knowledge of gene/transcript sequences, which prohibits the detection
of novel ones. Moreover, the dynamic range of mRNA expression levels in a cell is
huge: some have only few copies while the most abundant ones may have over 10,000
copies. However, Microarray usually suffers from loss of signal at very abundant
mRNAs, making it have less power on accurately quantifying these mRNAs [Wang
et al., 2009b]. Microarray is also limited to larger background noises due to hybridiza-
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tion, such as cross-hybridization or non-ideal hybridization kinetics [Tu et al., 2002,
Klebanov and Yakovlev, 2007].
1.1.4 RNA Sequencing (RNA-seq) of mRNA transcriptome
High-throughput sequencing technologies such as RNA-seq [Wang et al., 2009b] opens
a new era for investigation on the mRNA transcriptome. Generally, in an RNA-seq
experiment, the probed RNA molecules in the target transcriptome can be first syn-
thesized into double stranded cDNAs, followed by a monitored process of fragmenta-
tion that cuts the full-length cDNAs into shorter pieces. A sample of the generated
fragments usually with constrained length range (required by many sequencer) would
be selected to construct a cDNA library for further sequencing. The output of the
RNA-seq experiment is the single-end reads or paired-end reads, typically of length
100 200 bp, which are sampled from one end (single-end sequencing) or both ends
(paired-end sequencing) of the size-selected fragments. See Figure 1.5. If paired-
end sequencing is utilized, the original transcript fragments in the sample may be
inferred according to the distribution of the mate-pair distances estimated from the
data. Therefore, the produced RNA-seq reads are snapshots of subsequences of orig-
inal mRNA molecules in the transcriptome.
The RNA-seq technique has several advantages over microarrays. First, by di-
rectly sequencing the cDNA fragments, RNA-seq allows the investigation on known
transcripts and the exploration on novel ones. Second, It is capable of quantify-
ing a larger dynamics range of expression levels, with absolute rather than relative
values [Wang et al., 2009b]. Last, the hybridization issues seen with microarrays is
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Figure 1.5: RNA-seq. Short RNA-seq reads are sequenced from mRNA transcripts
in the transcriptome. Figure accommodated from www.wikepedia.com
.
eliminated in RNA-seq experiments. All these features make it suitable for transcript
level reconstruction and quantification.
Although the application of next-generation sequencing or high-throughput se-
quencing technologies on transcriptome analysis has not been not long, just since
year 2008 [Marguerat et al., 2008, Wang et al., 2009b], there have been abundant re-
search work that utilizes the deep sequencing coverage on a transcriptome of interest
for insights into the linkage from genotype to phenotype of various species. This new
type of biological data has raised many computational and methodological challenges
that excite the society of computational biology and bioinformatics, recognized by its
extraordinary volume and computational difficulty. The sequence file of every single
sample may take up to tens of Gigabytes in its binary format, consisting of tens or
hundreds of millions of read records, requesting unprecedented challenges in issues
such as data hosting, management, sharing, analyzing, and privacy control. On the
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other hand, the sequencing capabilities of current next-generation sequencing proto-
cols still limit the direct profile of transcriptome using raw RNA-seq reads. Ideally,
the sequencing procedure should reveal the diversity and abundance of a transcrip-
tome in a complete, accurate and unbiased manner. However, the interpretation of
sequencing output in practice is often complicated by read length, sampling cover-
age, sampling errors and various types of sampling biases. Some sequencing protocols,
such as platforms provided by 454 and Pacific Biosciences, may sequence reads up to
thousands of nucleotides that may directly showcase the sequences of most transcripts
and quantitate their abundance at the same time. Nonetheless the throughput and
the quality are often highly limited, leading to insufficient coverage on the transcrip-
tome. The RNA-seq experiments are mainstreamed by the short read sequencing
protocols provided by Illumina. This protocol generate reads typically of a length
less than 100 nucleotides, a length insufficient to identify the original transcript for
most of the reads. Great ambiguity exists in the survey of transcript isoforms present
in a sample and in the evaluation of their expression levels. Therefore, more and
more approaches have been developed for the computational solutions that bridge
short read sequences and biological findings. In the next section, we will review some
of the primary computational challenges emerged in short-read sequencing.
1.2 Computational analysis using RNA-seq
Compared with early achievements which investigate the genome mainly at gene
level, i.e. computational analysis is conducted on gene sequences, RNA-seq dives into
a higher resolution. It allows us to look at alternative splicing events, gene fusion
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and mutation/SNPs at mRNA transcript level, all of which are very important events
and may potentially relate to diseases.
With all these benefits brought by RNA-seq, urgent needs escalate for bridging
the gaps between the sequenced RNA-seq reads and the characterization of the tran-
scriptome. However, the sequenced RNA-seq reads carry only partial information of
original mRNA transcripts. Therefore, there exist many challenges for this task, such
as: read mapping which tries to find the exact location on the genome where each
RNA-seq reads may originate from, transcriptome assembly which aims at identifying
the mRNA transcripts presented in the cell, transcript isoform expression estimation
which quantifies the expression level of mRNA transcrips and etc. In this disserta-
tion, we primarily focus on the transcriptome assembly and transcript quantification
problems (quality and quantity assessment), which will reveal all characteristics of the
mRNA transcriptome and is critical for downstream studies, like differential analysis
between diseased and normal cells.
In this section, we will formally define the problem of transcriptome assembly and
transcript quantification and show the challenges in solving these problems. First,
we will briefly introduce RNA-seq read mapping.
RNA-seq reads alignment
The observed RNA-seq reads are sequences of ’A’, ’C’, ’G’ or ’T’, representing DNA
bases. RNA-seq read alignment aims at locating the exact genomic coordinates on the
genome where these reads are sampled from. This is achieved by aligning the reads
to a reference genome. A reference genome can be considered as a assembled genome
12
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Figure 1.6: Typical computational analysis with RNA-seq data. (a) RNA-seq reads
are sequenced from mRNA transcriptome. (b) RNA-seq short read alignment to the
reference genome. (c) Transcriptome assembly. (d) Transcript quantification.
database which gathered from the sequencing of DNA from a number of donors. When
a read is mapped as an entirety, it is referred as “exonic alignments”; otherwise, it
is referred as “spliced alignments” which spans multiple exons and consequentially
defines the splice sites of the splice junctions (Figure 1.6(b)). Here, the splice junctions
are actually the intron region on the genome before alternative splicing happens.
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Transcriptome assembly
Transcriptome assembly is a central problem of RNA-seq analysis, which aims at reca-
pitulating the variety of transcript isoforms in an mRNA transcriptome from from the
sequenced short reads. This procedure allows us to recover the genes and isoforms in
existing database, as well as to detect novel ones. A typical RNA-seq protocol works
by randomly fragmenting the mRNA transcripts followed by sequencing a sample of
the total fragments. Therefore, the sequences of RNA-seq reads carry partial informa-
tion of the original transcripts. After mapping the reads to the reference genome, the
genomic coordinates where the reads are aligned will help reveal the exonic segments
on the genome. The contiguous bases covered by read alignments constitute exons
of a particular gene. While the splice junctions of the spliced alignments infer the
intronic regions of that gene and indicate how the exons will be connected to form
an isoform.
Figure 1.6(c) illustrates one simple example of transcript reconstruction. Three
exons have been suggested by the RNA-seq read alignments along with three introns
implied by the splice junctions. According to the observed evidence, two transcript
isoforms can be reconstructed. One connects all three exons and the other skips the
middle exon.
Transcript quantification
Recent studies have estimated that as many as 95% of all multi-exon genes are al-
ternatively spliced, resulting in more than one transcript per gene [Pan et al., 2008b,
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Wang et al., 2008b]. Transcript quantification determines the steady state levels of
alternative transcripts within a sample, enabling the detection of differences in the
expression of alternative transcripts under different conditions. Its application in de-
tecting biomarkers between diseased and normal tissues can greatly impact biomedical
research. Using RNA-seq data, the quantity of one transcript isoform expressed is usu-
ally measured by a statistic related to the number of reads falling on it. This statistic
is calculated to approximate the number of mRNA molecule copies of such isoform.
However, this task is not trivial. Since isoforms within a gene share sequences, some-
times it is difficult to assign one read to a specific isoform. For example, as showed
in Figure 1.6(d), there are five exonic reads aligned on “Exon1”. Solely based on this
observation, we can hardly determine their origination. Through quantification, we
may identify four reads (green) coming from T1 and 10 reads (blue) coming from T2.
Therefore, the relative abundance of these two isoforms are 1 : 2.5.
Challenges in transcriptome assembly and quantification
Despite plenty of methods have been developed for solving the transcript reconstruc-
tion and quantification problems, they are still considered quite challenging. First, it
is commonly observed that “the more the isoforms, the harder to predict” [Li et al.,
2011b]. Intuitively, transcript isoforms from the same gene often overlap significantly.
Limited by current sequencing technology, the length of RNA-seq read is insufficient
(usually shorter than 200bp for a single-end read or about 500bp for a paired-end
read). A short read may be mapped to more than one transcript isoform. Determin-
ing the presence and expression of individual transcripts from short read alignment,
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therefore, can lead to an unidentifiable model, where no unique solution exists. Sec-
ondly, various sampling biases have been observed regularly in RNA-seq datasets as a
result of library preparation protocols. These biases typically include position-specific
bias [Bohnert and R., 2010, Li et al., 2010a, Roberts et al., 2011, Wu et al., 2011]
such as 3’ bias and transcription start and end biases, and sequence-specific bias [Li
et al., 2010b, Roberts et al., 2011, Turro et al., 2011], where the read sampling in the
transcriptome favors certain subsequences. How to compensate for these biases is an
open problem. Finally, though closely related, transcriptome assembly and quantifi-
cation are usually treated independently by existing methods. Typically, transcript
reconstruction methods are first employed to produce a candidate set of isoforms, and
quantification approaches may be further applied on the assembled set of isoforms
or the reference database to estimate their abundance. However, this strategy may
increase the risk of quantifying a false or incomplete set of transcripts. Moreover, it is
biologically unlikely to expect all candidate transcripts for a given gene to be signifi-
cantly expressed concurrently in a cell. Existing analytical approaches tend to assign
positive expression values to every candidate transcript provided, thereby creating
a situation in which large errors in abundance estimation can be computationally
introduced for transcript isoforms that may, in reality, barely be expressed.
To address these challenges, in this dissertation, we focus on developing a novel
and robust framework for comprehensive analysis of mRNA transcriptome both qual-
itatively and quantitatively, along with an accurate and consistent transcript abun-
dance measure.
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1.3 Thesis Statement
The aim of this dissertation is to develop computational methods for precise tran-
scriptome analysis using RNA-seq data. Three closely related problems are studied:
how to accurately estimate the abundance of the known transcript isoforms, how to
simultaneously discover the presence and quantities of novel transcripts, and how to
scale the transcriptome analysis to large-scale RNA-seq data. With prior knowledge
of annotated gene/isoforms, a generalized linear model has been developed to solve
the first problem which resolves the “unidentifiable” challenge in transcript quan-
tification and effectively handles the sampling biases. For the purpose of detecting
transcripts uncatalogued in existing database, a novel framework is designed that
takes advantage of the biological interpretability of read relations and simultaneously
infers the identities and quantities of the full-length gene isoforms residing in origi-
nal cells. Empowered by the advent of large, complex clinical RNA-seq datasets, a
systematic pipeline is built which aims to leverage information from massive sam-
ples and highlight meaningful transcription signals. All developed methods explore
efficient solutions of recovering the characteristics of mRNA transcriptome both qual-
itatively by assessing the diversity of the mRNAs and quantitatively by estimating
the abundance of the mRNAs from the RNA-seq read alignments. Meanwhile, they
fully enable the translation from raw sequencing data to clinical insights and also
provide valuable information differentiating functions of normal cells and diseased
ones.
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1.4 Contributions of this dissertation
In this dissertation, we have developed a series of computational methods targeting
a comprehensive analysis of the mRNA transcriptome. All methods are data-driven.
Salient information are mined and extracted from large-scale biological data, i.e.,
raw RNA-seq reads. Experiments on both simulated and real RNA-seq datasets
have demonstrated significantly improved sensitivity and specificity of our developed
methods as compared to other state-of-the-art approaches.
Accurate transcript abundance estimation given reference annotation
Transcript quantification is performed to determine the steady state levels of all the
alternative transcripts within a sample if a set of reference transcripts is provided.
The reference transcripts could either from annotation database, or from various tran-
script assembly softwares. A robust model has been developed, named MultiSplice,
which directly resolves three main challenges in the abundance estimation task: (1)
ambiguity in solution; (2) bias in read sampling and (3) low-expression transcripts.
First, MultiSplice adopts a general linear model which not only includes informa-
tion from single exons and splice junctions, but also leverages reads spanning multiple
splice junctions to ameliorate unidentifiability. Second, all possible sampling biases
are taken into account, like positional bias and sequence bias. The bias parameters
are embedded into the general model. Lastly, to achieve reasonable sparsity. LASSO
is utilized to solve the linear system in order to infer an accurate set of dominantly
expressed transcripts.
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Simultaneous transcript reconstruction and quantification
When the reference transcript database is incomplete or inaccurate, the transcriptome
assembly is needed for producing a complete and correct set of transcript isoforms.
An efficient and accurate algorithm has been proposed for simultaneous transcript
reconstruction and quantification directly from RNA-seq paired-end read alignments.
We have developed a novel method named Astroid for simultaneous transcript
reconstruction and quantification directly from RNA-seq paired-end read alignments.
Recall that in a typical RNA-seq experiment, mRNA molecules in the sample are
cleaved into fragments. Fragments with desired sizes are randomly selected and se-
quenced at one end (single-end sequencing) or both ends (paired-end sequencing).
Using paired-end sequencing, the original transcript fragments in the sample may be
inferred according to the distribution of the mate-pair distances estimated from the
data. However, the distance between sampled fragments, which disconnects the frag-
ments that belong to the same mRNA copy of a transcript, has barely been studied.
Existing methods typically overlook the relation among the transcript fragments and
assume independent sampling for the fragments. We instead propose to statistically
model the distance between sampled transcript fragments, and to use this informa-
tion to relate fragments and thread the observed reads into individual transcript
copies. The read alignments are represented using vertices of a flow network, con-
nected by edges that represent mate-pair distances and between-fragment distances.
The likelihood of each edge is evaluated according to the distance distributions pre
learned or specified distribution. A maximum likelihood set of transcript copies is
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then reconstructed by solving a minimum-cost flow problem on the flow network.
The number of copies for a transcript simultaneously provides a direct estimate for
the transcript quantity. Lastly, we introduce a set of rules that clusters homogeneous
vertices and edges and compresses the flow network. A compression parameter is
defined to leverage the time and space complexity required by the flow network and
the model accuracy.
Transcriptome analysis on large-scale data
The rapid development of sequencing technology allows us to sequence a sample or
tissue at a much lower cost. For example, nowadays an RNA-seq experiment typi-
cally costs less than $1, 000, comparable to the cost of microarray. Recently, several
projects have been launched which take advantage of this advancement and sequence
tens of thousands of samples aiming at a comprehensive understanding of cell func-
tioning as well as cell differentiation, such as TCGA (The Cancer Genome Atlas)
and ICGC (International Cancer Genome Consortium). The massive amount of data
not only brings more power for expanding our knowledge of human genome, but
also introduces great challenges. First, high volume of data means high demand of
computing and storage resources. Second, large-scale data from heterogeneous sam-
ples/tissues incurs ambiguity of a overall analysis: the uncertainty will be extremely
amplified when examining all assemblies simultaneously. Therefore, the joint analysis
of hundreds of transcriptome is not simply a trivial extension from existing methods.
Driven by the desire of finding biological signatures from TCGA breast cancer
projects (819 samples included), we systematically investigate the current standard
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pipelines for processing large-scale RNA-seq datasets. They can be divided into two
categories: reference transcriptome guided and reference transcriptome independent.
The first one solely quantifies the annotated transcripts and the latter one starts by
reconstructing a transcript set then estimates their abundances. Both strategies treat
each individual sample independently which involves heuristic and potential filtering
on every sample. Furthermore, their performances are limited by the difficulties of
assembling and quantifying full-length transcripts on massive datasets. Alternatively,
we have developed an ab initio workflow which establishes a joint analysis model
that summarizes all samples with a single splice graph without the knowledge of
gene/isoform annotations. In stead of per-sample analysis, information is pooled
together for detection of aberrant alternative splicing markers. To our best knowledge,
this is the first method directly targeting the above challenges and dedicated to large-
scale transcriptome analysis.
Summary
If we consider the sequencing process as fragmenting the mRNA transcriptome into
millions of smaller pieces, each of which corresponds to a short RNA-seq reads. The
effort of this dissertation is like seeking solutions of piecing the puzzle together to
recapitulate the original picture. The problem itself is quite challenging due to the
large quantity of puzzle pieces. It can be further complicated by real applications,
such as: sampling biases introduced during sequencing procedure, analogous to the
circumstance that pieces from another puzzle set are mixed in; the need of comparing
a large set of similar but slightly different puzzles, analogous to the comparison of hun-
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dreds of transcriptome; and etc. The methods developed in this dissertation directly
address the computational challenges in “solving the puzzle” and have demonstrated
superior effectiveness and efficiency in transcriptome analysis.
Copyright c© Yan Huang, 2015.
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Chapter 2 Related work in RNA-seq-based transcriptome analyses
In this chapter, we will summarize the general analysis of mRNA transcriptome using
RNA-seq data including the computational challenges and the current solutions.
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Figure 2.1: The typical workflows in the transcriptome studies using RNA-seq tech-
nologies.
Figure 2.1 illustrates a typical workflow in the transcriptome studies. Although
the high-throughput RNA-seq reads provides an unprecedented opportunity to pre-
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cisely profile the mRNA transcriptome of a specific cell population, the observed
RNA-seq reads are still local pieces of the original transcripts, bringing great ambi-
guity to the effort of portraying the transcriptome. How to reconstruct the original
transcriptome with the RNA-seq reads remains a challenging problem. Generally, the
current methodologies of addressing this problem can be divided into two categories:
reference-guided and reference-independent referring to whether or not the analysis is
guided by the reference genome or transcriptome. The reference-independent meth-
ods are greatly useful when a reference genome is not available or when individual
modifications to the reference genome is significant. The representative approaches
are Trinity [Grabherr et al., 2011] and Trans-ABySS [Birol, 2009], which are known as
the de novo assembly. They assemble mRNA transcripts solely based on nucleotides
sequenced in RNA-seq reads without the guidance of any reference, which may fol-
lowed by downstream analysis (Figure 2.1). When a reference genome/transcriptome
is accessible, as for human for example, the other category, usually first align the
reads to the reference genome [Wang et al., 2010a, Trapnell et al., 2009b] or tran-
scriptome [Langmead et al., 2009a]. Transcripts can be reconstructed and quantified
according to the genomic coordinates or the mapped reads. Compared with de novo
methods, it is computational efficient regarding the time cost and memory usage, and
most importantly, it has been demonstrated to have higher sensitivity and specificity
in the subsequent assembly step [Garber et al., 2011b]. Here, we limit the discussion
of this dissertation in the scope of reference-guided methods. In the following sections
we will briefly introduce the existing work for reference-guided transcriptome studies
and their problems.
24
2.1 RNA-seq read alignments
There exist two threads of work of read mapping approaches: the unspliced aligners
and the spliced aligners [Garber et al., 2011a].
The unspliced aligners usually rely on the access to the exact or similar reference
transcriptome of a specified species. Reads are mapped to a reference without al-
lowing any large gaps. The representative work include but not limited to MAQ [Li
et al., 2008], SHRiMP [Rumble et al., 2009], ELAND [Cox, 2007], Novoalign [Hercus],
Stampy [Lunter and Goodson, 2011], Bowtie [Langmead et al., 2009b], BWA [Li and
Durbin, 2009], Bowtie 2 [Langmead and Salzberg, 2012] and SNAP [Zaharia et al.,
2011].
However, the nature of unspliced aligners make them of limited use since they can
only identify known exons and splice junctions. Alternatively, the spliced aligners
map the reads to the genome where reads can span multiple exonic regions separated
by introns on the genome. This kind of methods allow the detection of novel exons,
junctions, and therefore novel transcript isoforms, making it more suitable for a com-
prehensive analysis of the mRNA transcriptome. Several methods are developed in
this category, including: TopHat [Trapnell et al., 2009b], SpliceMap [Au et al., 2010],
MapSplice [Wang et al., 2010b], GSNAP [Wu and Nacu, 2010], STAR [Dobin et al.,
2013] and etc.
By first mapping the reads to the reference genome/transcriptome, we obtain
the genomic coordinates of all possible exon and junction boundaries while build a
foundation for recapitulating the mRNA transcriptome.
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2.2 Ab initio transcript reconstruction
A handful of computational methods for transcript reconstruction have been devel-
oped to bridge the gap from the sequenced short read alignments to the identity of
the original transcripts [Trapnell et al., 2010b, Guttman et al., 2010, Li et al., 2011b,
Huang et al., 2012].
A common simplification in existing transcript reconstruction approaches is to
reconstruct transcripts from a small set of features extracted from the reads. Most
approaches, for example, Scripture [Guttman et al., 2010] and IsoLasso [Li et al.,
2011b], build a splice graph [Heber et al., 2002, Hu et al., 2012] in which nodes stand
for the exons and the edges stand for the splice junctions. Each path on the splice
graph represents a possible transcript. Cufflinks [Trapnell et al., 2010b] summarizes
the read alignments with a partial order list, based on the mutual compatibility
whether two reads may be explained by one transcript. A set of expressed transcripts
is then solved on the splice graph or the partial order list, typically combined with
transcript-level heuristics or shrinkage such as maximum parsimony [Trapnell et al.,
2010b], maximum sensitivity [Guttman et al., 2010] and Lasso [Li et al., 2011b]
(Figure 2.2).
However, the simplification relying on extracted features that current methods
made ignore the relation among the reads – as long as the features extracted from
the reads, or the probabilities of the read being sampled from each transcript, or
the collective statistics do no change, how the reads are distributed cannot provide
additional information.
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Figure 2.2: (a) Splice graph built from RNA-seq read alignments. (b) and (c) show
two different strategies of transcript assembly. (b) refers to maximal parsimony which
gives rise to only two isoform transcripts that can explain all reads. (c) refers to
maximum sensitivity that generates all possible transcript isoforms from the splice
graph.
Moreover, since they typically work from the exons and the splice junctions re-
vealed from the RNA-seq read alignment. One central difficulty of transcript recon-
struction becomes solving the combinatorial ambiguity in linking splice isoforms of dif-
ferent alternative splicing events into full transcripts. Heuristics are what the existing
assembly methods usually rely on. For example, on the basis of maximum parsimony,
Cufflinks Trapnell et al. [2010b] will choose the minimum set of transcripts that can
explain the observed fragments. Following maximum sensitivity, Scripture Guttman
et al. [2010] will keep all putative isoforms, subject to later biological filtering. Other
methods, such as IsoLasso Li et al. [2011b], apply L1-regularization (known as Lasso)
to reinforce transcript set shrinkage by favoring candidates with higher estimated
abundance. Each of these transcript-level heuristics reflects a general sense about
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what true transcript isoforms could look like. For example, the philosophy behind
maximum parsimony is that the most concise set of transcripts necessary to explain
the data tends to have sufficient sensitivity and high specificity, and that behind reg-
ularization is that transcripts with very low expression are likely the artifacts due to
sampling ambiguity. Nonetheless, the intention of these heuristics focus on how to
select one optimal combination of exons and splice junctions which is the secondary
structure inferred from read or fragment alignments, while ignoring the linkage re-
lationship among the transcript fragments which would reveals the original mRNA
molecules more directly.
2.3 Transcript abundance estimation
The problem of transcript quantification is often treated separately from transcript
assembly. A common simplification is to assume independent and random sampling
of reads. This assumption allows processing each read individually with a same model
to calculate the probability that a read is sampled from a transcript [Trapnell et al.,
2010b, Li and Dewey, 2011, Nicolae et al., 2011]. Alternatively, this assumption
allows efficient inference with only a few collective statistics, such as the number of
reads mapped to each exon [Jiang and Wong, 2009, Huang et al., 2012, Bohnert and
R., 2010].
However, these simplifications ignore the relation among the reads – as long as
the features extracted from the reads, or the probabilities of the read being sampled
from each transcript, or the collective statistics do no change, how the reads are dis-
tributed cannot provide additional information. For example, the two sets of reads in
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Figure 2.3a suggest the same splice graph hence contain the same information regard-
ing possible transcripts. According to maximum parsimony, for instance, the two sets
of reads may be explained by the same two transcripts. However, the distribution of
the reads may suggest two different sets of transcripts. Figure 2.3b, shows two read
distributions that contain the same number of reads but have drastically different
coverage profiles. Collectively, the two loci will get the same FPKM Trapnell et al.
[2010b], Li et al. [2011b], i.e., the Fragments Per Kilobase of transcript per Million
mapped reads. However, the relative location of the reads in set 2’ may suggest an
additional transcription termination that distinguishes two transcripts of different
expression levels. This also demonstrates the advantage of performing transcript re-
construction and quantification simultaneously, as alleviating the risk of estimating
transcript abundance on the basis of an incorrect set of transcripts.
Read set 2 Read set 2’
Read set 1 Read set 1’
Figure 2.3: The read sets 1 and 1’. Two read sets have the same number of reads.
The read sets 2 and 2’, Two read sets have the same number of reads. Different read
distributions may suggest different set of transcripts.
Another problem is the current measurement for transcript quantity based on read
count may be skewed in practice. The typical unit FPKM requires that the number of
fragments sampled from each transcript is strictly proportional to the length and the
number of molecule copies of the transcript. However, this correlation may become
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poor especially for short transcripts (e.g. ∼ 14% of transcripts in human genome are
less than 1000nt, according to UCSC GAF 2.0 annotation), because these transcripts
may be fragmented into smaller pieces that will not be sequenced due to size selec-
tion in RNA-seq James [2011]. The presumed correlation may further weakened by
sampling biases (e.g. GC-content biases and positional biases Bohnert and R. [2010],
Roberts et al. [2011]) and read mapping errors. Furthermore, FPKM normalizes rel-
ative expression according to the total number of mapped reads in one sample, which
may not reflect the true library size and may bias comparison of transcript expres-
sion across samples Wagner et al. [2012], Dillies et al.. Another measure TPM [Li
and Dewey, 2011, Wagner et al., 2012], i.e., Transcripts Per Million, resolves this
inconsistency problem. It approximates the transcript number by normalizing the
cumulative per base read coverage by the isoform length. The library size is esti-
mated by summing up the estimated abundance of all isoforms accounting for the
total number of transcripts in the transcriptome. However, it is unclear how well
the per base coverage in TPM can approximate the true abundance of one isoform
because it is impossible that all observed fragments can be tightly arranged one after
the other making every single base of the isoform covered by the read.
Copyright c© Yan Huang, 2015.
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Chapter 3 A Robust Method for Transcript Quantification with
RNA-seq Data
In this chapter, we introduce a robust method for transcript-level quantification.
Transcript isoforms can differ not only in exons alternatively included or excluded but
also in where two or more exons are connected together. In RNA-seq data, this infor-
mation is typically implied by the spliced reads, i.e., the reads that cross one or more
splice junctions. We have developed a general linear model for transcript quantifica-
tion that leverages discriminative features in spliced reads to ameliorate the issue of
identifiability and simultaneously corrects the sampling bias. Our contribution of this
method is three-fold: (1) We explicitly identify MultiSplice, a novel structural feature
consisting of a contiguous set of exons that are expected to be spanned by the RNA-
seq reads or transcript fragments of a given length. The MultiSplice, which includes
single splice junctions as a special case, is used in two ways: its presence in the sample
will infer the host transcript while its absence may reject it. MultiSplices are more
powerful than single exons in disambiguating transcript isoforms, making more tran-
script quantification problems identifiable with long or paired-end reads; (2) We set
up a linear system which minimizes the summed relative squared errors regarding the
ratio of the expected expression against the observed expression across all structure
features along a gene while taking into account various bias effects; (3) We develop
an iterative minimization algorithm in combination with LASSO [Tibshirani, 1996]
to resolve the aforementioned linear system in order to achieve the most accurate set
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of dominantly expressed transcripts while simultaneously correcting biases.
We have demonstrated the efficacy of our methods on both simulated RNA-seq
datasets and real RNA-seq data: (1) We conducted the first study to investigate the
question: what is the maximum read length needed in order to disambiguate all possi-
ble transcript isoforms in transcriptomes from different species; (2) We compared the
proposed method with several state-of-the-art methods including Cufflinks, RSEM,
the Poisson model, and the ExonOnly model. Our results using simulated data from
the human mRNA transcriptome demonstrated superior performance of the proposed
method in most cases. When applied to 8 RNA-seq datasets from two breast can-
cer cell lines (MCF-7 and SUM-102), the quantification obtained from MultiSplice
demonstrated good consistency within technical replicates from each transcriptome-
wide assessment and substantial differences between the two biological groups (cell
lines) in a small percentage of genes.
3.1 Method
In this section, we propose a method designated MultiSplice, for mRNA isoform
quantification. We first define the observed features used in the MultiSplice model
and the statistics collected. Then, we derive a general linear model to relate transcript
level estimate to the observed expression on every feature.
Preliminaries. For a gene g, we use Eg to denote the set of exonic segments [Jiang
and Wong, 2009, Li et al., 2011b] in g, which are disjoint genomic intervals on the
genome that can be included in a transcript in its entirety. We use Tg to denote the
set of mRNA isoforms transcribed from g. These mRNAs can be a set of annotated
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Figure 3.1: Overview of the MultiSplice model. a. Sequenced RNA-seq short-reads
are first mapped to the reference genome using an RNA-seq read aligner such as
MapSplice [Wang et al., 2010a]. In the presence of paired-end reads, MapPER [Hu
et al., 2010] can be applied to find PER fragment alignments for the entire transcript
fragment based on the distribution of insert size. b. Observed coverage on each exonic
segment. c. Four transcripts originate from the alternative start and exon skipping
events. Provided with these transcripts, abundance estimates would be unidentifiable
for methods that only use coverage on exonic segments. Both transcript profiles P1
and P2, for instance, can explain the observed read coverage on each exon, but deviate
from the true transcript expression profile. d. MultiSplices that connect multiple
exonic segments in a transcript. e. A linear model can be set up where the expected
coverage on every exonic or MultiSplice feature approximates its observed coverage.
The transcript expression is solved as the one that minimizes the sum of squared
relative error.
transcripts retrieved from a database such as Ensembl [Ens] or Refseq [Ref]. A
transcript t ∈ Tg is defined by a sequence of exon segments, t = et1et2 · · · etnt , where
e ∈ Eg and nt denotes the number of exonic segments in the transcript t. The length of
each exonic segment e is defined as the number of nucleotides in the exonic segment,
denoted as l(e). Hence, the length for every transcript is l(t) =
∑nt
i=1 l(e
t
i).
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3.1.1 MultiSplice
In a typical RNA-seq dataset, a significant percentage of the read alignments are
spliced alignments that connect more than one exon. With paired-end reads, the
transcript fragment where its two ends are sampled can be inferred based on the
distribution of the insert size [Roberts et al., 2011]. Transcript fragments are typ-
ically between 200bp and 300bp, making them more likely to cross multiple exons,
indicating these exons are present together in one transcript. This information can
be crucial in distinguishing alternative transcript isoforms. However, they are often
ignored in current computational approaches.
In this subsection, we consider a sequence of adjacent exons in an mRNA tran-
script covered by transcript fragments. These structural features are the basis of
MultiSplice. For generality, we assume that the RNA-seq reads are sampled from
transcript fragments whose lengths follow a given distribution Ffr with probability
density function ffr. For example, the fragment length distribution Ffr is often
modeled as a normal distribution with mean and variance learned from the genomic
alignment of the RNA-seq reads. We also assume the maximum fragment length is
lfr.
Definition Let b = etie
t
i+1 · · · eti+nb be a substring of a transcript sequence t =
et1e
t
2 · · · etnt , nb ≥ 1 and i+ nb ≤ nt. Then b is a MultiSplice in t if and only if
nb−1∑
q=1
l(ei+q) ≤ lfr − 2. (3.1)
The condition in Equation 3.1 guarantees that a MultiSplice b connects nb + 1 adja-
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cent exons with at least 1 base landed on the 5’ most exon eti and the 3’ most exon
eti+nb . We use Bg to denote the set of all MultiSplices in gene g. From the definition,
the set of MultiSplices vary according to the fragment length lfr. The longer the
fragments, the more MultiSplices are expected to function as structural features, and
the higher power in disentangling highly similar alternative isoforms.
In Figure 3.1, for example, assume the maximum fragment length is lfr = 300bp
with the expected fragment length of 250bp and the exonic segments of this gene have
lengths of l(e1) = 200bp, l(e2) = 200bp, l(e3) = 100bp, l(e4) = 200bp, l(e5) = 200bp.
In reference transcript T1 = e1e3e5, b2 = e1e3e5 is a substring of T1, and we have
l(e3) = 100bp < 300bp = lfr which allows a fragment to cover b2. Therefore, b2
is a MultiSplice feature of the gene. Combining MultiSplices from all the reference
transcripts, b1, b3, b5, b6, and b7 are MultiSplices consisting of a single splice junction,
b2, b4, b8, b9, and b10 are MultiSplices consisting of two splice junctions.
3.1.2 Expected coverage and observed coverage
Given the gene g and a transcript t ∈ Tg, let ci be the number of transcript fragments
covering the ith nucleotide of t. We define the coverage on t as the averaged number
of transcripts covering each base in the transcript, C(t) = 1
l(t)
∑l(t)
i=1 ci. Then C(t) is
an estimator for the quantity of t in the sample, which provides a direct measure for
the expression level of t. In our model, C(t) is the unknown variable. The feature
space that can be observed from the given RNA-seq sample is the union of all exonic
segments and MultiSplices of the gene, Φg = Eg ∪ Bg. We aim at resolving the
transcript expressions that minimize the difference between the observed expression
35
and the expected expression of every feature.
The observed coverage on an exonic segment e ∈ Eg is defined as C(e) = 1l(e)
∑l(e)
i=1 ci,
where ci is the number of reads covering the ith nucleotide in e. The read coverage
C(e) provides an estimator for the number of transcript copies that flow through the
exonic segment e assuming uniform sampling. For a MultiSplice b ∈ Bg, we use C(b)
to denote the read coverage on b defined as the number of transcript fragments that
include b.
For every φ ∈ Φg and every transcript t ∈ Tg, the expected coverage of feature φ
from t can be expressed as a function of the transcript quantity C(t), i.e., E[C(φ|t)] =
m(φ, t)C(t), where m(φ, t) contains the probability of observing φ in t assuming
uniform sampling. Next, we define the expected coverage on exonic segments and
MultiSplice respectively.
For an exonic segment e in t, assuming Nt fragments were sampled from t, the
number of fragments falling in e then follows a binomial distribution with parameters
Nt and p(e|t), where p(e|t) = l(e)l(t) denotes the probability that a fragment sampled
from t originated from e. Therefore, the expected number of reads on e from t is
E[Ne|t] = Ntp(e|t). Let fr1, fr2, · · · , frNt be the fragments sampled on t, the expected
fragment coverage on t is E[C(t)] = E[
∑Nt
i=1 l(fri )
l(t)
] = NtE[l(fr)]
l(t)
, where E[l(fr)] is the
expected fragment length. On the other hand, the expected fragment coverage on
e contributed by t is calculated as E[C(e|t)] = E[E[C(e|t)|Ne|t]] = E[
Ne|tE[l(fr)]
l(e)
] =
E[Ne|t]E[l(fr)]
l(e)
= Ntp(e|t)E[l(fr)]
l(e)
. Since p(e|t) = l(e)
l(t)
, p(e|t)
l(e)
= 1
l(t)
. Therefore, we could get
E[C(e|t)] = NtE[l(fr)]
l(t)
, which means the expected fragment coverage on e contributed
by t equals the expected fragment coverage of t, which concludes that the probability
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of observing e in t is 1: m(e, t) = 1.
For a MultiSplice b = etie
t
i+1 · · · eti+nb , we are interested in the number of fragments
containing it. Should a transcript fragment fr cover b, fr must start no later than
the 3’ end boundary of the 5’ most exonic segment eti and have at least 1 base landed
on the 3’ most exonic segment eti+nb . Therefore, there exists a window w(b) before the
3’ end of eti with length l(w(b)) = l(fr)−
∑nb−1
q=1 l(ei+q)−1, where b can be covered by
the transcript fragment fr. The probability that fr covers b in transcript t is hence
p(b|t) = l(fr)−
∑nb−1
q=1 l(ei+q)−1
l(t)
. Equivalent to the expected number of fragments from t
that contain b, the expected fragment coverage on b from t is E[C(b|t)] = E[Nb|t] =
E[Ntp(b|t)] = Nt
E[l(fr)]−
∑nb−1
q=1 l(ei+q)−1
l(t)
. Since E[C(b|t)] = m(b, t)C(t), the probability
that the MultiSplice b is observed within transcript t is m(b, t) = E[C(b|t)]
C(t)
. Recall
that C(t) = NtE[l(fr)]
l(t)
, therefore, m(b, t) =
E[l(fr)]−
∑nb−1
q=1 l(ei+q)−1
E[l(fr)]
. In Figure 3.1, for
example, m(b2, T1) =
E[l(fr)]−l(e3)−1
E[l(fr)]
= 250−100−1
250
= 0.6.
In summary, the probability that a feature φ contained in a uniformly sampled
transcript fragment fr is:
m(φ, t) =

1 if φ ⊂ t and φ ∈ EG
E[l(fr)]−
∑nb−1
q=1 l(ei+q)−1
E[l(fr)]
if φ ⊂ t and φ ∈ BG
0 if φ 6⊂ t.
(3.2)
with φ ⊂ t standing for that φ is contained in t.
3.1.3 A generalized linear model for transcript quantification
We construct a matrix M′ ∈ <|Φg |×|Tg | to represent the structure of the transcripts,
whose entry on the row of φ and the column of t corresponds to the probability of
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observing feature φ from transcript t, M′(φ, t) = m(φ, t). The linear model is set
up for every feature φ ∈ Φg by equating the observed coverage on φ to the expected
coverage from all transcripts:
C(φ) =
∑
t∈Tg
M′(φ, t)C(t) + εφ, for any φ ∈ Φg. (3.3)
Here C(t) ≥ 0 for every t ∈ TG, εφ is the error term for feature φ in transcript t.
Lemma 3.1.1 The MultiSplice model for transcript quantification is identifiable if
the rank of M ′ is no less than the number of transcripts |Tg|.
Lemma 3.1.1 directly follows the the Rouché-Capelli theorem [Horn and Johnson,
1990].
3.2 Bias correction
Under uniform sampling, the sampling probability is the same at every nucleotide of
a transcript. The observed coverage on φ is unbiased for the expected coverage on
t. In this case, the bias coefficient σ(φ, t) is set to 1 for all transcripts and features.
However, sampling bias is often introduced in RNA-seq sample preparation protocols
and has been demonstrated to have significant effects in RNA-seq analysis [Kozarewa
et al., 2009, Wang et al., 2009a]. Therefore, we discuss in the following subsections
how MultiSplice corrects various sampling bias via learning of the bias coefficients and
simultaneously solves the linear model for transcript coverage C(t) of every transcript
t.
Figure 3.5(a-e) shows how various types of sampling bias alter the sampling prob-
ability and hence the coverage. Two types of sampling bias are commonly observed in
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RNA-seq data, namely, the position-specific bias and the sequence-specific bias [Bohn-
ert and R., 2010, Roberts et al., 2011, Olejniczak et al., 2010, Srivastava and Chen,
2010]. In our model, sampling bias may affect the sampling probability of both the
exonic segments and MultiSplices. Therefore, we calculate the bias coefficient σ(φ, t)
for every feature φ ∈ Φg and every transcript t so that E[C(φ|t)] = σ(φ, t)m(φ, t)C(t).
Next, we introduce each independent bias individually.
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Figure 3.2: Sampling bias present in the RNA-seq data. a. RNA-seq read coverage
under uniform sampling. b. RNA-seq read coverage under uniform sampling with
transcript start/end bias. c. RNA-seq read coverage under uniform sampling with
sequence-specific bias. d. RNA-seq read coverage under uniform sampling with 5’/3’
position-specific bias. e. RNA-seq read coverage under uniform sampling with all
aforementioned types of bias. f. Sampling bias on gene CENPF in the breast cancer
dataset used in Section 6. Please note that the second peak in the coverage plot is not
an exon in CENPF. The observed coverage on each exon decreases almost linearly
from the 3’ end to the 5’ end. The coverage also drops at the bases near the end of
the gene. The non-uniformity in the two middle large exons is likely to be due to the
sequence-specific sampling bias.
3.2.1 Sequence-specific bias.
The sequence-specific bias refers to the perturbation of sampling probability related
to certain sequences at the beginning or end of transcript fragments [Roberts et al.,
2011, Li et al., 2010b]. The characteristic of this type of bias in the given RNA-seq
39
sample can be learned in advance by examining the relationship between GC content
and the observed coverage on single-isoform genes. To derive the sequence-specific
bias at an arbitrary exonic position, we look into 8bp upstream to the 5’ start to
11bp downstream according to [Roberts et al., 2011]. A Markov chain is constructed
to model the effect on the sampling probability at the position from the sequence
of surrounding nucleotides. Then we use an approach based on the probabilistic
suffix tree [Bejerano, 2004] to learn the sequence-specific bias coefficient α(t, i) for ith
nucleotide in transcript t.
3.2.2 Transcript start/end bias.
Sampling near transcript start site or transcript end site is often insufficient. The
read coverage in these regions is typically lower than expected because the positions
where a sampled read can cover are restricted by the transcript boundaries. The bias
coefficient for start/end bias at the ith nucleotide in transcript t is written as:
β(t, i) =

i/E[l(fr)] if i < E[l(fr)]
1 if E[l(fr)] ≤ i ≤ l(t)− E[l(fr)]
(l(t)− i)/E[l(fr)] if i > l(t)− E[l(fr)].
3.2.3 5’/3’ position-specific bias.
Position-specific bias refers to the alteration on sampling probability according to
position in the transcript. For example, nucleotides to the 3’ end of the transcript
have higher probability to be sampled in Figure 3.5(f). Here we model the position-
specific bias coefficient as a linear function, γ(t, i) = γt1 · i+γt0. The intercept γt0 gives
the bias coefficient at the 5’ transcript start site. The slope γt1 measures the extent
of the bias: a positive γt1 indicates that 3’ transcript end site has higher sampling
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probability than the start site; a zero γt1 indicates no positional bias in the transcript
t.
3.2.4 Combined bias model.
Assuming the above three types of bias have independent effect on read sampling,
we derive the bias coefficient at ith nucleotide in transcript t as σ(t, i) = α(t, i) ·
β(t, i) · γ(t, i). The bias coefficient of an exonic segment e ∈ Eg is then the averaged
bias coefficient on all positions in the exonic segment e, and the bias coefficient of
a MultiSplice b ∈ Bg is the averaged bias coefficient on all positions in its sampling
window w(b). In summary, the bias coefficient for a MultiSplice feature φ ∈ Φg in
transcript t is
σ(φ, t) =

∑
i∈φ σ(t,i)
l(φ)
if φ ⊂ t and φ ∈ Eg∑
i∈wφ σ(t,i)
E[l(w(φ))]
if φ ⊂ t and φ ∈ Bg
0 if φ 6⊂ t.
(3.4)
3.3 Solving the general linear models with bias correction
Conventionally, we are interested in the set of transcript expressions that minimize
the sum of squared errors, the absolute residuals between the expected coverage and
the observed coverage. This solution is relatively sensitive to unexpected sampling
noise which often occurs in real RNA-seq samples and may lead to a highly unstable
extrapolation when the expression of the alternative splicing events discriminating
the transcripts is notably lower than the average level of gene expression. Therefore,
we define the sum of squared relative errors (SSRE), which measures the relative
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residual regarding the ratio of the expected coverage against the observed coverage.
SSRE =
∑
φ∈Φg
(∑
t∈Tg σ(φ, t)M
′(φ, t)C(t)
C(φ)
− 1
)2
. (3.5)
3.3.1 Bias parameter estimates.
Among all the bias parameters, the sequence-specific bias is learned in advance while
the start and end bias is a function of transcript fragment length. The only bias
parameters unknown related to the 3’ bias are defined by the intercept γt0 and slope
γt1 for every transcript t ∈ Tg. Therefore, we use an iterative-minimization strategy
and search for a set of bias coefficients γt0’s and γ
t
1’s that better fit the RNA-seq
sample than the uniform sampling model. We start with the transcript coverage
C(t)’s that are solved from the uniform sampling model (with γt0 = 1 and γ
t
1 = 0
as initial condition). Analogous to the hill climbing algorithm [Russell and Norvig,
2003], we then iteratively probe a locally optimal set of transcript coverage together
with the bias coefficients around the uniform solution through minimizing the SSRE.
In each iteration, a candidate solution is obtained through sequentially setting the
partial derivatives to 0 with respect to every unknown parameter γt0, γ
t
1, C(t), and
for every transcript t ∈ Tg. If the candidate solution results in a smaller SSRE, the
candidate solution is taken and the iteration continues.
We use an iterative-minimization strategy to search for a set of bias coefficients
γt0’s and γ
t
1’s for every transcript t ∈ Tg that better fit the RNA-seq sample than
the uniform sampling model. We initiate the iterations with the transcript coverage
C(t)’s solved from the uniform sampling model and the bias coefficients γt0 = 1 and
γt1 = 0. In each iteration, for transcript t we set:
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1. ∂SSRE
∂C(t)
= 0; 2.∂SSRE
∂γt1
= 0; 3. ∂SSRE
∂γt0
= 0.
∂SSRE
∂C(t)
= 0
⇒
∑
φ∈Φg
2(C(φ)−
∑
s∈Tg
σ(φ, s)M′(φ, s)C(s)) · σ(φ, t)M′(φ, t) = 0
⇒
∑
s∈Tg
C(s)(
∑
φ∈Φg
σ(φ, s)M′(φ, s)σ(φ, t)M′(φ, t)) =
∑
φ∈Φg
C(φ)σ(φ, t)M′(φ, t)
⇒ C(t) =
∑
φ∈Φg C(φ)σ(φ, t)M
′(φ, t)∑
φ∈Φg σ(φ, t)M
′(φ, t)σ(φ, t)M′(φ, t)
−
∑
s∈Tg ,s 6=tC(s)(
∑
φ∈Φg σ(φ, s)M
′(φ, s)σ(φ, t)M′(φ, t))∑
φ∈Φg σ(φ, t)M
′(φ, t)σ(φ, t)M′(φ, t)
.
σ(φ, t) is the only function related to γt1 and γ
t
0.
∂SSRE
∂γt1
= 0
⇒
∑
φ∈Φg
2(C(φ)−
∑
s∈Tg
σ(φ, s)M′(φ, s)C(s)) · ∂σ(φ, t)
∂γt1
M′(φ, t)C(t) = 0
⇒ C(t)
∑
φ∈Φg
σ(φ, t)M′(φ, t)
∂σ(φ, t)
∂γt1
M′(φ, t)
=
∑
φ∈Φg
C(φ)
∂σ(φ, t)
∂γt1
M′(φ, t)−
∑
s∈Tg ,s 6=t
C(s)(
∑
φ∈Φg
σ(φ, s)M′(φ, s)
∂σ(φ, t)
∂γt1
M′(φ, t)).
Similarly,
∂SSRE
∂γt0
= 0
⇒
∑
φ∈Φg
2(C(φ)−
∑
s∈Tg
σ(φ, s)M′(φ, s)C(s)) · ∂σ(φ, t)
∂γt0
M′(φ, t)C(t) = 0
⇒ C(t)
∑
φ∈Φg
σ(φ, t)M′(φ, t)
∂σ(φ, t)
∂γt0
M′(φ, t)
=
∑
φ∈Φg
C(φ)
∂σ(φ, t)
∂γt0
M′(φ, t)−
∑
s∈Tg ,s 6=t
C(s)(
∑
φ∈Φg
σ(φ, s)M′(φ, s)
∂σ(φ, t)
∂γt0
M′(φ, t)).
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Because σ(φ, t) is a linear combination of γt1 and γ
t
0, and hence
∑
φ∈Φg σ(φ, t)M
′φ, t
is also the linear combination of γt1 and γ
t
0. Then we can directly calculate
∂σ(φ,t)
∂γt1
and
∂σ(φ,t)
∂γt0
.
3.3.2 Solving the linear model with LASSO regularization.
Lastly, we solve for the level of individual transcript expression with additional regu-
larization, based on the bias coefficients from the previous step. One common problem
in transcript quantification is that the set of expressed transcripts are not known a
priori. Hence it becomes crucially important to identify the set of truly expressed
transcripts provided in a candidate set. Therefore, we further apply the L1 regular-
ization (known as LASSO) for its proven effectiveness in irrelevance-removal and solve
for the set of transcript expression C(Tg) that minimizes the following loss function
L = SSRE + L1 penalty =
∑
φ∈Φg
(∑
t∈Tg σ(φ, t)M
′(φ, t)C(t)
C(φ)
− 1
)2
+ λ||C(Tg)||1
where λ ≥ 0 denotes the weight of the L1 shrinkage and C(t) ≥ 0 for every t ∈ Tg.
3.4 Experimental Results
To evaluate the performance of the MultiSplice model, we compared it with four other
approaches. The ExonOnly model, where only exonic segments are used to represent
transcript composition as proposed in SLIDE [Li et al., 2011a], was implemented
using a linear regression approach with LASSO. The ExonOnly model provided the
baseline comparison for MultiSplice. The Poisson model, which was originally pro-
posed by [Richard et al., 2010], was implemented in C. Two read-centric models:
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Cufflinks [Trapnell et al., 2010c] which uses the reads aligned to the reference genome
and RSEM [Li and Dewey, 2011] which uses the reads aligned to the set of reference
transcript sequences are analyzed. Cufflinks 1.1.0 was downloaded from its website
in September, 2011. RSEM 1.1.13 was downloaded in November, 2011.
These algorithms were run on both simulated datasets and real datasets. Reads
were first mapped by MapSplice 1.15.1 [Wang et al., 2010a] to the reference genome. If
the read was paired-end, MapPER [Hu et al., 2010] was applied to infer the alignment
of the entire transcript fragment.
3.4.1 Transcriptome identifiability with increasing read length
We first study how the increase in read length may alleviate the lack of identifiability
issues in transcript quantification using MultiSplice. We downloaded UCSC gene
models in human (track UCSC genes:GRCh37/hg19), mouse (track UCSC Genes:
NCBI37/mm9), worm (track WormBase Genes: WS190/ce6) and fly (track FlyBase
Genes: BDGP R5/dm3). We computed the feature matrix used in MultiSplice given
variable read length and determined its rank. The transcript isoforms of a gene is
identifiable if the rank of the feature matrix is no less than the number of transcripts.
Figure 3.3 plots the additional number of genes that become identifiable as the read
length increases from 50bp assuming single-end read RNA-seq data. For all four
species, as the read length increases, MultiSplice is capable of resolving the transcript
quantification issues of more genes. With 500bp reads, about 98% genes in both
human and mouse become identifiable. Surprisingly, for worm and fly, 500bp reads
do not gain significant improvement over 50bp reads. This is mostly due to the
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fact that the exon lengths of fly and worm are comparably much longer [Fox-Walsh
et al., 2005] than human and mouse, making it difficult for reads of moderate size
to take effect. With current short read technology where read length is typically
100bp or less, paired-end reads with the size of transcript fragments around 500bp
may be the most economical and effective for transcription quantification for genes
with identifiability issues. This is under the assumption that it is possible to infer the
transcript fragment from paired-end reads based on the tightly controlled distribution
of insert-size.
Figure 3.3: Changes in mRNA identifiability as a function of transcript fragment/read
length. Starting from levels achieved with 50bp single-end reads, the left side of the y-
axis shows the additional number of genes that become identifiable using MultiSplice
as the read length increases. The y-axis on the right side shows the total percentage
of genes for which mRNA transcript structures are resolved. The UCSC annotated
transcript sets of four species: human, mouse, fly and worm were used for this analysis.
3.4.2 Simulated human RNA-seq experiment
Data Simulation. Due to the lack of the ground truth within real datasets, simu-
lated data has become an important resource for the evaluation of transcript quan-
tification algorithms [Bohnert and R., 2010, Li et al., 2010a, Nicolae et al., 2011]. We
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developed an in-house simulator to generate RNA-seq datasets of a given sampling
depth using UCSC human hg19 annotation. The simulation process consists of three
steps: (1) randomly assign relative proportions to all the transcripts within a gene
and set this as the true profile; (2) calculate the number of reads to be sampled from
each transcript; (3) sample transcript fragments of a given length along the tran-
scripts according to the per base coefficient σ(t, i) = kiα(t,i)β(t,i)
l(t)
+1 for the ith base on
transcript t, where α(t, i) and β(t, i) are the sequence-specific bias and the transcript
start/end bias as defined in Section 4 and k is the slope of the position-specific bias.
Paired-end reads will be generating by taking the two ends of the transcript frag-
ment. Please note the sequence bias per base has been learned from a real dataset, a
technical replicate of MCF-7 data that will be introduced in the next section.
Accuracy measurement. Due to inconsistencies in the normalization scheme
used by different software, the estimated abundance may not be comparable among
different approaches. Hence, we computed relative proportions of transcript isoforms
for each method. The similarity between the estimated result and the ground truth is
measured by both Pearson correlation and Euclidean distance. Pearson correlation is
the accuracy measurement used in rQuant [Bohnert and R., 2010]. Let X denote the
vector of real isoform proportions of a gene and X̂ denote the estimated proportions.
The formula of the correlation is: r(X, X̂) = cov(X, X̂)/(σX · σX̂). A value close
to 1 means that our estimation is highly accurate and vice versa. Below, we adopt
a boxplot to illustrate the performance of each method. The box is constructed
by the 1st quartile, the median, and the 3rd quartile. The ends of the upper and
lower whisker are given by the 3rd quartile +1.5× IQR(inner quartile range) and 1st
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quartile −1.5 × IQR, respectively. Due to the space limit, we present the result of
correlation measurement in the main manuscript.
Varying read lengths. On the premise of the same sequencing depth, we would
like to find out whether or not the read length will affect the estimation results. 40
million RNA-seq fragments were simulated from the human transcriptome. 2x50bp
paired-end reads (insert size around 150bp) were generated from these fragments. A
50bp single-end read set was constructed by simply throwing out the second read of
each pair and the 100bp single reads were obtained by taking the 100bp prefix of the
transcript fragments. This configuration allows a fair evaluation about the effect of
varying read lengths by eliminating difference from random read sampling.
As shown in Figure 3.4, the performance of MultiSplice, RSEM and ExonOnly
method improves as the read length increases. Accuracy of the Poisson model does
not change much with varying read lengths. It is surprising to see that Cufflinks
achieves better correlation with 100bp single-end reads than both 2x50bp paired-end
reads and 50bp single-end reads. This is probably because the transcript fragment
inference from paired-end reads may not be accurate for Cufflinks. Both MultiSplice
and RSEM show higher median correlation and lower variance compared with other
methods under different read lengths, which indicates that MultiSplice and RSEM
are capable of leveraging longer reads for more accurate estimation as RNA-seq tech-
nologies improve.
Varying sampling depth. Next we evaluate how the sequencing depth may af-
fect the accuracy of transcript abundance estimation. Four groups of 2x50bp paired-
end synthetic data were generated on the whole human transcriptome with increasing
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number of reads: 5 million, 10 million, 20 million and 40 million. Since the exonic
regions of different genes may overlap, we quantify isoforms within a genomic lo-
cus [Trapnell et al., 2010c]. 13364 genomic loci with multiple isoforms are selected
for analysis. The loci were divided into three subsets: (1) 12413 loci to which identifi-
ability holds for all methods; (2) 498 loci to which identifiability holds for MultiSplice;
(3) 453 loci to which identifiability does not hold for all methods.
For each subplot in Figure 3.5(a, b, c), the estimation accuracy for all methods
generally improves as more reads are sampled. For the loci whose identifiability con-
ditions are satisfied for all methods, the estimated transcript proportion is highly
similar with the ground truth, with an median correlation close to 0.9 for all meth-
ods. In the second category, when the genes are still identifiable with MultiSplice, the
estimation accuracy of MultiSplice and RSEM remain high, with an median correla-
tion above 0.8 while others slip below 0.7. For the category when identifiability is not
satisfied for all methods, the estimation accuracy is degraded even more. However,
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Figure 3.4: a-c. Boxplots of the correlation between estimated transcript proportions
and the ground truth under varying read length. (a),(b) and (c) correspond to the
estimation results on 40M 50bp single-end reads, 40M 100bp single-end reads, and
40M 2x50bp paired-end reads, respectively.
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MultiSplice still consistently gives better estimation results indicating that the in-
clusion of MultiSplice features make transcript quantification more stable than other
methods. Cufflinks demonstrated the worst performance in this category with largest
variance as also shown in Figure 3.7(c), mainly because the unidentifiability condi-
tions make it difficult to assign these reads to a transcript. Instead, it throws out
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Figure 3.5: a-c. Boxplots of the correlation between estimated transcript proportions
and the ground truth under varying number of sampled reads: 5M, 10M, 20M and
40M over a total of 13364 genomic loci with more than one isoforms. (a), (b) and (c)
correspond to the loci set that is identifiable with basic exon structure, identifiable
with additional MultiSplice features, and unidentifiable, respectively. d-f: Boxplots
of the correlation between estimated transcript proportions and the ground truth
under four circumstances: uniform sampling, sampling with positional bias only,
with sequence bias only and with all bias. (d), (e) and (f) correspond to the loci set
that is identifiable with basic exon structure, identifiable with additional MultiSplice
features, and unidentifiable, respectively.
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Figure 3.6: a-c. Boxplots of the Euclidean distance between estimated transcript pro-
portions and the ground truth under varying read length. (a), (b) and (c) correspond
to the estimation results on 40M 50bp single-end reads, 40M 100bp single-end reads,
and 40M 2x50bp paired-end reads, respectively.
most of multi-mapped reads. Apparently, increasing sampling depth cannot alleviate
the issue of unidentifiability.
Bias correction. To study the effect of the bias correction, we have simulated
data with uniform sampling, sampling with only positional bias, sampling with only
sequence bias, and sampling with the combined positional and sequence bias. Here,
we set the slope of the position-specific bias k to 2 with 40 million 2x50bp paired-end
reads sampled from the whole transcriptome for each case. All the approaches achieve
the best results when the sampling process is uniform. As positional or sequence bias
is introduced, their performance tapers down. The presence of both positional and se-
quence biases has the largest impact in all methods. Meanwhile, because MultiSplice
and Cufflinks correct both sequence and positional bias and RSEM could adjust po-
sitional bias, these three methods are more robust and outperform the ExonOnly and
the Poisson methods.
Inference of expressed transcripts. Quantification of mRNAs usually relies
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Figure 3.7: a-c. Boxplots of the Euclidean distance between estimated transcript
proportions and the ground truth under varying number of sampled reads: 5M, 10M,
20M and 40M over a total of 13364 genomic loci with more than one isoforms. (a),
(b) and (c) correspond to the loci set that is identifiable with basic exon structure,
identifiable with additional MultiSplice features, and unidentifiable, respectively. d-f:
Boxplots of the Euclidean distance between estimated transcript proportions and the
ground truth under four circumstances: uniform sampling, sampling with positional
bias only, with sequence bias only and with all bias. (d), (e) and (f) correspond to
the loci set that is identifiable with basic exon structure, identifiable with additional
MultiSplice features, and unidentifiable, respectively.
on a set of candidate transcript structures as input. It is unknown in a priori whether
each transcript is present in a sample or not. Therefore, accurate quantification
methods should be able to infer the transcripts that are expressed as well as those that
are not. To assess the capability of the various methods to infer expressed transcripts,
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Figure 3.8: a-c. Boxplots of the correlation between estimated transcript proportions
and the ground truth. (a), (b) and (c) correspond to the loci set that is identifiable
with the basic exon structure, identifiable with additional MultiSplice features, and
unidentifiable, respectively. d-f. Comparison of false positive rates in the inference of
the expressed transcripts. Thresholds represent the minimum fraction of a transcript
that is considered expressed. (d), (e) and (f) correspond to the loci set that is
identifiable with the basic exon structure, identifiable with additional MultiSplice
features, and unidentifiable, respectively.
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Figure 3.9: a-c. Boxplots of the Euclidean distance between estimated transcript
proportions and the ground truth for inference of dominant transcripts. (a), (b)
and (c) correspond to the loci set that is identifiable with the basic exon structure,
identifiable with additional MultiSplice features, and unidentifiable, respectively.
we generated 40 million simulated 2x50bp paired-end reads from human genes with at
least 3 transcripts. We randomly chose two transcripts from one gene and simulated
reads only from these transcripts. The remaining transcripts were not sampled. We
used the false positive rate to measure the accuracy of the inference. Non-expressed
transcripts that were estimated with a positive abundance above a given threshold
were counted as the false positives. As shown in Figure 3.8(a, b, c), MultiSplice
and RSEM demonstrated best estimation accuracy and further more MultiSplice
demonstrated the lower false positive rate in the identification of dominant transcripts
in Figure 3.8(d, e, f). Poisson and Cufflinks tended to assign positive expression to
every transcript including those that are not expressed. MultiSplice, in general,
outperformed the others in identifying the correct set of expressed transcripts.
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3.4.3 Real human RNA-seq experiment
We applied the set of transcript quantification methods to a dataset that was origi-
nally used by Singh et al. to study differential transcription [Singh et al., 2011]. In
this study, two groups of RNA-seq datasets were generated from SUM-102 and MCF-
7, two breast cancer cell lines. Each group contains 4 samples as technical replicates.
The RNA-seq data were generated from Illumina HISEQ2000. Each sample had ap-
proximate 80 million 100bp single-end reads. About 60 million reads can be aligned
to the reference genome by MapSplice. The UCSC human hg19 annotated transcripts
were fed into each software for transcript quantification.
Since ground truth expression profiles do not exist for the real datasets, we investi-
gated whether the different methods provided a consistent estimation within samples
of technical replicates which only vary by random sampling. In contrast, a significant
number of genes between MCF-7 and SUM-102 were expected to be differentially
expressed [Singh et al., 2011]. To evaluate this, we computed Jensen−Shannon di-
vergence (JSD), used in Cuffdiff [Trapnell et al., 2010c] to measure the dissimilar-
ity between two samples and calculated the within-group and between-group differ-
ences. As detailed in Figure 3.10(a), MultiSplice, Cufflinks and RSEM had smaller
average within-group difference than the average between-group difference while the
other two methods do not show clear difference. MultiSplice demonstrated higher
between-group difference than both Cufflinks and RSEM, but also had relatively
higher within-group differences as well. Most of these, however, were well below a
JSD of 0.2 and considered to be insignificant. A closer look at a number of cases
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showed that occasionally MultiSplice and Cufflinks may overestimate or underesti-
mate the between-group difference respectively. Figure 3.10(b) (The complete figure
with 8 samples can be found in the Figure 3.11(a)) shows a gene where Cufflinks
underestimated the difference between the two groups. The second isoform of the
gene AIM1 has a unique first exon (chr6:106989461-106989496). Clear difference in
the read coverage on this exon can be observed between the two groups, indicating
strong differential levels of expression, i.e., the second isoform is barely expressed in
MCF-7 while almost comparable to the first isoform in SUM-102 cells. The between
group square root of JSD is 0.21 by Cufflinks, lower than 0.39 by RSEM and much
lower than 0.50 by MultiSplice.
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Figure 3.10: a. Boxplots of the within-MCF-7, within-SUM-102, and between-group
square root of JSD of all genes for all methods. b. A case where Cufflinks underesti-
mated the difference between the two groups. The second isoform of Gene AIM1 has
a unique first exon, whose read coverage differs significantly between the two groups.
A detailed plot with all 8 samples can be found in the Figure 3.11(a).
The exon-skipping event found in gene CD46 is also differentially expressed (Fig-
ure 3.11(b)). The estimation of transcript quantification with MultiSplice was con-
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sistent with the observation in the qRT-PCR data showing that steady state levels
of transcripts with the skipped exon were present in amounts more than two fold
higher expression in SUM-102 than in MCF-7 cells. An additional example is shown
in Figure 3.12.
Computational Performance. We also compared the running time and mem-
ory usage of the proposed method with Cufflinks and RSEM. In order to make a fair
comparison, we only measured the computational performance of transcript quantifi-
cation for each software. One sample with 76 million reads from MCF-7 was used for
analysis. The reads are aligned to the reference transcript set by Bowtie [Langmead
et al., 2009a] for RSEM and to the reference genome by MapSplice [Wang et al.,
2010a] for MultiSplice and Cufflinks. The results presented here were run on Intel
Xeon X5650 (Westmere) 12-core 2.66 GHz Linux server with 32GB of RAM and
single-thread enabled.
Table 3.1 summarize the comparison results of MultiSplice, Cufflinks and RSEM.
Table 3.1: Computational performance comparison
Method Type MultiSplice Cufflinks RSEM
QuantificationTime 40min 74min 23h
MemoryUsage < 1G 2G 7G
3.5 Discussion
In this chapter, we have presented a general linear framework for the accurate quan-
tification of alternative transcript isoforms with RNA-seq data. We introduce a set of
new structural features, namely MultiSplice, to ameliorate the issue of identifiability.
57
AIM1
AIM1
MCF7_SM6_HS
MCF7_SM4_HS
MCF7_11_HS
MCF7_5_HS
SUM102_12_HS
SUM102_10_HS
SUM102_SM6_HS
SUM102_SM7_HS
UCSC Genes (RefSeq, UniProt, CCDS, Rfam, tRNAs & Comparative Genomics)
MCF7_SM6_HS
77 _
0 _
MCF7_SM4_HS
52 _
0 _
MCF7_11_HS
97 _
0 _
MCF7_5_HS
104 _
0 _
SUM102_12_HS
663 _
0 _
SUM102_10_HS
485 _
0 _
SUM102_SM6_HS
317 _
0 _
SUM102_SM7_HS
328 _
0 _
(a)
CD46
CD46
CD46
CD46
CD46
CD46
CD46
CD46
MCF7_SM6_HS
MCF7_SM4_HS
MCF7_11_HS
MCF7_5_HS
SUM102_12_HS
SUM102_10_HS
SUM102_SM6_HS
SUM102_SM7_HS
UCSC Genes (RefSeq, UniProt, CCDS, Rfam, tRNAs & Comparative Genomics)
MCF7_SM6_HS
379 _
0 _
MCF7_SM4_HS
221 _
0 _
MCF7_11_HS
298 _
0 _
MCF7_5_HS
340 _
0 _
SUM102_12_HS
610 _
0 _
SUM102_10_HS
581 _
0 _
SUM102_SM6_HS
833 _
0 _
SUM102_SM7_HS
856 _
0 _
(b)
Figure 3.11: a. The coverage plot of Gene AIM1 in all 8 breast cancer cell line
samples. Please note the first exon of the second isoform is barely expressed MCF-7
but its expression significantly increased in the SUM-102 samples. b. The coverage
plot of Gene CD46. The exon-skipping event on the 13th exon has been confirmed
by qRT-PCR.
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Figure 3.12: One real gene example for which MultiSplice inferred the expressed tran-
script while RSEM and Cufflinks failed to do so. The left figure shows the coverage
plot of Gene PODXL in all 8 breast cancer cell line samples. The between group
square root of JSD is 0.290611 by MultiSplice, 0.195271 by Cufflinks and 0.094207
by RSEM. The exon-skipping event on the seventh (chr7: 131194995-131195090) are
differentially expressed between two cell lines. The coverage plot indicates the first
isoform is not expressed in SUM-102. The right part shows pie charts of estimated
relative expression of the annotated two isoforms for three methods in all 8 samples.
Except MultiSplice, both Cufflinks and RSEM assign positive expression to the first
isoform in SUM-102.
With MultiSplice features, 98% of UCSC gene transcript models in human and mouse
become identifiable with 500bp reads (or paired-end reads with 500bp transcript frag-
ments), an 8% increase from 50bp. Therefore, longer reads or paired-end reads with
longer insert-sizes rather than further increases in sequencing depths can be crucial
for the accurate quantification of mRNA isoforms with complex alternative transcrip-
tion, even though a majority of the genes have relatively simple transcript variants.
The results also demonstrate the robustness of the MultiSplice method under various
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sampling biases, consistently outperforming three other methods: Cufflinks, Pois-
son and ExonOnly and comparable to RSEM. The application of our approach to
real RNA-seq datasets for transcriptional profiling successfully identified a number of
isoforms whose proportion changes differed significantly between two distinct breast
cancer cell lines.
Copyright c© Yan Huang, 2015.
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Chapter 4 Simultaneous Transcript Reconstruction and Quantification
In this chapter, we revisit the problem of transcript reconstruction. Instead of assign-
ing reads probabilistically to a set of isoforms, we go one step further by answering
how well individual reads may be pieced together to build copies of individual tran-
scripts. We directly reconstruct effective transcript copies, each of which corresponds
to a chain of non-overlapping transcript fragments (Figure 4.1). The contribution
of each effective copy to the abundance of the corresponding isoform does not solely
depend on the number of reads observed, but also on how consistent the distribution
of the observed fragments is as compared to the expected process of mRNA frag-
mentation and sampling. This procedure allows us to explicitly take into account of
the positional relationships among reads, which were generally ignored by existing
methods. In the meantime, the total number of transcript copies constructed can be
used to assess the transcript abundance. Therefore, we introduce a new measure for
transcript quantification, namelyeTPM, effective Transcripts Per Million. The eTPM
of an isoform i is calculated as:
eTPMi =
eTi × 106∑
j eTj
(4.1)
where eTi is the number of effective copies of isoform i and
∑
j eTj accounts for the
total number of transcripts in the transcriptome. With our approach, not only do
the constructed effective copies convey the information of the exon composition of
the transcript, but the number of copies also delivers an estimation of the relative
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abundance of each isoform. It is therefore truly simultaneous in terms of transcript
identification and quantification.
To this end, we have developed a novel computational algorithm Astroid(Transcript
reconstruction through assembly of effective transcript copies guided by the fragment
distance.). We model the relation of all observed reads using a directed flow network,
with reads connected by edges whose weight represents the likelihood that two reads
may coexist in a transcript. The most likely set of transcript copies is reached by
solving a min-cost flow problem given the flow network. A compression scheme is
developed to speed up the performance for genes with high read coverage. The model
is further consolidated by adding MultiSplice features [Huang et al., 2012], reads
that span multiple alternative splicing events, to avoid the identification of spurious
transcripts.
We have compared the performance of our method with a number of state-of-the-
art methods including Cufflinks [Trapnell et al., 2010b], Scripture [Guttman et al.,
2010], IsoLasso [Li et al., 2011b] and Trinity [Grabherr et al., 2011]. Simulation
studies on the human transcriptome datasets have demonstrated Astroid’s superior
sensitivity and precision on transcript discovery. The eTPM estimate calculated
from the number of effective transcript copies assembled by Astroid has exhibited
an improved correlation with true transcript abundance than FPKM estimates. The
evaluations on the MAQC human brain dataset and the Alexa-seq dataset further
demonstrated the effectiveness of our method in real applications, in which Astroid
provided slightly more consistent estimates for transcript abundance with qRT-PCR
validations than other methods.
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Figure 4.1: Reconstruction of effective transcript copies by Astroid. (a) The two
isoforms from which transcript fragments are randomly sampled. (b) The alignments
of the sampled fragments, plotted with IGV Thorvaldsdóttir et al. [2013]. A splice
graph can be built based upon the exons and splice junctions identified from the
fragment alignments. (c) Effective transcript copies assembled by Astroid. Astroid
successfully reconstructs the two expressed isoforms with no false positive. (d) The
distribution of fragments in the effective copies. The likelihood of each copy is assessed
according to the sizes of the fragments in the copy together with the between-fragment
distances. Effective transcript copies will be identified and used to measure the
abundance of each isoform. Note that this example shows only transcript fragments
rather than the RNA-seq reads for simplified illustration. However, our method does
take paired-end reads as input.
4.1 Effective Transcripts
We propose to construct a set of effective transcript copies which simultaneously
explain the observed reads and estimate the transcript abundance. The notations
used in this section and the following method sections are summarized in Table 4.1.
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Table 4.1: Notations in the main manuscript.
Symbol Meaning
i isoform
t transcript copy
Ni read count on isoform i
N total read count in the transcriptome
len(·) length of · (read, transcript, etc.)
Rfrt set of sampled fragments in copy t
Rgapt set of between-fragment gap in copy t
d(·) fragment/gap size distribution
eTi effective transcripts of isoform i
PW (·|δi, η) characterized Weibull distribution
φ(v) exon is splice graph a read v is mapped to
ρ(φ(v1), φ(v2)) a splice graph path between two exons
f(e) the amount of flow on edge e
γ compression parameter
π read cluster
b MultiSplice feature
c(e) capacity on edge e in RFN
ψ(b) size of the sampling window of b
The sampled fragments typically do not immediately follow each other and frag-
ments may not be sampled immediately at the start/end of a transcript. We model
the positional relationship among the fragments by considering the size distribution
of 1) the fragments, 2) the gap between two adjacent fragments, and 3) the gap from
the transcription start site to the first fragment and from the last fragment to the
transcription termination site. We use Rfrt to denote the set of transcript fragments
in a copy t. Each fragment can be identified by a mate pair of reads. The set of
between-fragment gaps in t is denoted as Rgapt .
The likelihood of the transcript t is then interpreted as the joint likelihood of all
its fragments together with the gaps according to their sizes. To simplify the model,
we assume that the sizes of the fragments and the gaps follow the same distribution,
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whose density function is denoted as d(·).
Let isoform i be the isoform that t is copied from, denoted as t ∈ i. Because differ-
ent copies may have different number of component fragments, we use the geometric
mean of the probabilities of all fragments and gaps in t to evaluate the likelihood of
t,
L(t) =
 ∏
r∈Rgapt
d(len(r))
∏
r∈Rfrt
d(len(r))
 1|Rgapt |+|Rfrt | .
Generally, L(t) represents a central tendency of the probability of the fragments and
gaps contained in t. It is possible to model the size distribution of the gaps differ-
ently, with more complex distributions. However, as the experimental results have
suggested, the approximation in our simplified model is sufficient. The distribution
of d(·) will be discussed later in this section.
We further determine the effectiveness of a copy t by assessing the probability of
observing a copy with likelihood no greater than L(t).
Definition For a transcript t, let It denote the subdomain of the size density d(·)
such that ∀x ∈ It, d(x) ≤ L(t). Then t is effective if the cumulative density
integrated over all x ∈ It is no greater than a significance level τ , i.e.,
∫
It d(x) dx ≤ τ ,
where τ controls the probability of falsely considering t as ineffective.
As a convention in hypothesis testing, τ is often set as 0.05. For a given τ , the set
of all effective transcript copies of isoform i is denoted as: Si = {t :
∫
It d(x) dx ≤ τ}.
Then the abundance of isoform i is measured by the number of its effective copies,
called effective transcripts (eT), eTi = |Si|.
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Under the assumption of a uniformly random fragmentation process, the size
distribution of the fragments generated from isoform i can be approximated as a
characterized Weibull distribution [Griebel et al., 2012, Tenchov et al., 1985] with
two parameters δi and η. The isoform-specific shape parameter δi depends on the
logarithm of the molecule length of i, and the scale parameter η reflects the fragmen-
tation intensity which is constant across all transcripts in one experiment [Griebel
et al., 2012]. In this paper, the distribution of d(·) is approximated using the Weibull
distribution, d(·) = PW (·|δi, η).
4.2 Effective Transcripts per Million (eTPM)
We define the relative expression estimate effective transcripts per million of isoform
i by normalizing eTi by the total effective transcript copies in the transcriptome
(Equation 4.1).
There exist two other measurements focusing on quantifying the relative isoform
expression levels. They are both based on the number of reads on the isoform. One
is FPKM [Trapnell et al., 2010b]. For an isoform i, it approximates the transcript
abundance by normalizing the number of fragments on the isoform Ni by the isoform
length len(i), and uses the total number of fragments per million as a measure of
total transcripts in the transcriptome (Equation 4.2). However, when comparing the
isoform abundance among samples, the latter approximation is not accurate due to
the variant size distribution of the transcripts among different samples [Wagner et al.,
2012].
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FPKMi =
Ni
len(i)
103
· N
106
=
Ni · 109
len(i) ·N
(4.2)
Another measure TPM [Li and Dewey, 2011, Wagner et al., 2012], i.e., Transcripts
Per Million, resolves the inconsistency problem. It approximates the transcript num-
ber by normalizing the cumulative per base read coverage by the isoform length.
TPM of an isoform i is then calculated as in Equation 4.3 with summing up the
estimated abundance of all isoforms accounting for the total number of transcripts in
the transcriptome.
TPMi =
Nilen(r)
len(i)
· 106∑
j
Nj len(r)
len(j)
=
Nilen(r) · 106
len(i) ·
∑
j
Nj len(r)
len(j)
(4.3)
Here len(r) refers to the expected fragment length.
However, it is unclear how well Ni × 103/len(i) in FPKM and Nilen(r)/len(i) in
TPM can approximate the true abundance of one isoform because it is impossible
that all observed fragments can be tightly arranged one after the other (Figure 4.1b)
making every single base of the isoform covered by the read.
Unlike FPKM or TPM, eTPM explicitly considers the possible gaps between two
adjacent fragments on the same transcript copy. Since eTPM is normalized by the
total number of transcripts in a sample, it can be invariant across samples [Wagner
et al., 2012]. While both FPKM and TPM treat each read independently and consider
them as the same, the effective transcripts used in eTPM is assessed according to
the distribution of their fragments. In real experiments, the position distribution of
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sampled fragments may not be uniform due to PCR amplification error [Aird et al.,
2011] or sampling biases [Li et al., 2010b, Roberts et al., 2011, Turro et al., 2011].
The affected reads will form ill transcripts copies with only small fractions sampled.
These ill transcripts will be recognized during the eTPM calculation, which allows
for a more robust abundance measure (Figure 4.1d).
Although this measurement relies on the quantity of assembled effective copies
rather than the number of reads, it is derived based on the same assumption as the
other measurements regarding the abundance. Longer transcripts require more reads
to construct an effective copy. Hence eTPM of different transcripts can be compared
directly without the normalization by transcript length.
4.3 Method
The assembly of effective transcript copies with RNA-seq reads is achieved by solv-
ing a minimum-cost flow problem. In this section, we detail the modeling of the
problem, its solution and various improvements over the basic approach. The input
to our method is the genomic alignments of the paired-end reads to the reference
genome [Trapnell et al., 2009a, Wang et al., 2010a]. Another important data struc-
ture we used is the splice graph [Heber et al., 2002, Hu et al., 2012, Rogers et al.,
2012, Xia et al., 2011] (Figure 4.1b). The splice graph is constructed directly from the
read alignments using the method described by Hu et al. [Hu et al., 2012], and will
be used to infer potential transcripts where a pair of reads come from. In general, the
exons are identified as the genomic regions covered by abundant reads. These exons
constitute the vertices of the splice graph. The spliced read alignments contain splice
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junctions, each of which spans a pair of exons. The splice junctions make the edges
in the splice graph, whose directions can be defined by the direction of the transcrip-
tion. In addition, the donor and acceptor sites of a splice junction also determine the
boundaries of an exon. A path in the splice graph corresponds to (part of) a possible
isoform.
4.4 Read Flow Network
We model the relationships among reads using a flow network, namely the Read
Flow Network RFN = 〈V,E,W, source, sink〉. The vertex set V corresponds to the
union of the set of reads and the set of transcription start/termination sites (The
transcription start sites and termination sites can be either inferred as the genomic
positions that exhibit certain characteristic signatures [Kapranov, 2009, Yamashita
et al., 2011] or provided from existing transcript annotation). There are two types
of edges between two read vertices, the in-fragment edges and the between-fragment
edges. The in-fragment edges (denoted as Ein) refer to edges between reads generated
from the same fragment. In the case of paired-end reads, the edge is between the two
mates of a paired read. The between-fragment edges (denoted as Ebtwn) refer to the
edges that connect one fragment with its downstream fragment. In this case, an edge
usually connects the 3’ end read of a fragment (or a transcription start site) to the
5’ end of a downstream fragment (or a transcription termination site). Let φ(v) be
the exon in the splice graph where a read v is aligned to. For two vertices v1, v2 ∈ V ,
There exists an edge between v1 and v2 for each unique path ρi(φ(v1), φ(v2)) between
exon φ(v1) and exon φ(v2) in the splice graph. In presence of alternative splicing,
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Figure 4.2: (a) Alignments of the sequenced paired-end RNA-seq reads on the refer-
ence genome. (b) The read flow network that relates reads with in-fragment edges
(dashed arrows) and between-fragment edges (solid arrows). (c) Solve a minimum
flow (colored) on the read flow network. (d) The assembled effective transcript copies
with maximized likelihood.
there may exist more than one paths in the splice graph from φ(v1) to φ(v2). In this
case, multiple edges may be added to include all paths.
The weight of an edge e, e ∈ E corresponding to a path ρi(φ(v1), φ(v2)) between
two reads v1 and v2, reflects the likelihood of the two reads coming consecutively
from the same transcript copy. It is evaluated by the probability of observing a
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portion between v1 and v2 on path ρi(φ(v1), φ(v2)). For e ∈ Ein and e ∈ Ebtwn, len(e)
denotes the size of the observed fragment and size of the between-fragment gap,
respectively. Assuming both sizes follow a Weibull distribution, then the probability
of e is calculated as P (e) = PW (len(e)). The weight of e in RFN is defined as the
negative logarithm of its likelihood, w(e) = − logP (e).
Lastly, the network RFN is augmented by adding a virtual source and a virtual
sink to initiate and terminate all transcript copies. Directed edges will be built
from source to all vertices that correspond to transcription start sites and from all
vertices that correspond to transcription termination sites to sink. Moreover, one
edge is added to connect source to sink. The weights on these edges are always set
as 0. Because every read may only originate from one transcript copy, the capacity
constraint on every vertex that represents a read is set as 1. The capacities on source,
sink and vertices that represent transcription start/termination sites all equal to the
number of vertices that represent the reads.
In this way, each transcript copy can be represented as a source to sink path
(flow) (Figure 4.2b). Let T denote one set of transcript copies in RFN . For every
copy t ∈ T , the likelihood of t can be evaluated as the product of the probabilities of
its reads (vertices included in t), the probabilities of its distances connecting paired-
end reads (in-fragment edges in t) and the probabilities of its distances connecting
transcript fragments (between-fragment edges in t). The transcript copies in T are
considered mutually independent because the vertices and edges included in one copy
are exclusive. Hence, the likelihood of T can be written as the joint probability of all
the transcript copies in T ,
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P (T ) =
∏
t∈T P (t) (4.4)
=
∏
t∈T
∏
v∈t∩V P (v)
∏
e∈t∩Ein P (e)
∏
e∈t∩Ebtwn P (e).
The probability of a read P (v) can be calculated by considering the quality of its
alignment quality [Li and Dewey, 2011]. The probability of an edge P (e) has been
defined as PW (len(e) = l|e). Then the maximum likelihood set of transcript copies
can be written as,
T̂ = arg maxT logP (T ) (4.5)
= arg maxT
∑
t∈T
(∑
v∈t∩V logP (v) +
∑
e∈t∩Ein logP (e) +
∑
e∈t∩Ebtwn logP (e)
)
= arg minT
∑
t∈T
(∑
v∈t∩V − logP (v) +
∑
e∈t∩Ein − logP (e) +
∑
e∈t∩Ebtwn − logP (e)
)
.
Therefore, the problem of solving the maximum likelihood set of transcript copies
is equivalent to a minimum-cost flow problem [Ahuja et al., 1993a, Edmonds and
Karp, 1972] on the flow network RFN ,
T̂ = arg min
f(·)
∑
e∈E
w(e) · f(e), (4.6)
where f(e) is the amount of flow on every edge e.
Generally, solving a minimum-cost flow problem requires the pre-knowledge of
the amount of flow sending from source to sink, denoted as k. Here k is set as a
comparably large value (e.g. the total number of reads), the edge connecting source
to sink will consume the extra amount of flow beyond the number of transcript copies
which flow through the read vertices.
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4.5 Acceleration with compressed flow network
The time complexity of the algorithms solving the minimum-cost flow problem is
O(|V |3) [Ahuja et al., 1993b, Goldberg and Tarjan, 1989, Orlin, 1997], |V | is the
number of vertices. Given the size of reads, which could be in the order of millions,
the problem can be intractable. Here we introduce a heuristic to compress the read
flow network into a much smaller network with minimal loss of accuracy. The idea
is to remove highly repetitive reads in high coverage region by clustering these reads
into groups while still retaining the relationships among them. Given a compression
parameter γ, the vertex set V of the flow network can be partitioned into a set of
clusters Π = {π1, π2, · · · , πc} of V , such that the reads within each cluster contain
consistent splice junctions; have homogenous out-going edges and differ at most γ
bases at both boundaries (Figure 4.3).
1. Vertex homogeneity. ∀v1, v2 ∈ πi, πi ∈ Π, v1 and v2 are either both the 5’ end
reads of one fragment or both the 3’ end, and v1 and v2 either have the same
set of splice junctions in their alignments or have no splice junctions;
2. Edge homogeneity. ∀v1, v′1 ∈ πi, ∀v2, v′2 ∈ πj, πi, πj ∈ Π, there exists no edge
between v1 and v
′
1 or between v2 and v
′
2, and the edges between v1 and v2
represent the same set of paths in the splice graph as the edges between v′1 and
v′2;
3. Alignment adjacency. ∀v1, v2 ∈ πi, πi ∈ Π, the 5’-most base of v1 is at most
γ bases away from that of v2 on the genome, and the same for their 3’-most
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Figure 4.3: An example of the compressed flow network. Reads colored black are grouped into 3
clusters (light gray). Edges connecting the reads in the original RFN are collapsed into two edges
(colored orange) in the compressed network. The two reads colored green cannot be clustered into
π2 because they violate the vertex homogeneity and alignment adjacency, respectively.
bases.
In this way, the vertex set V can be reduced to the set of vertex clusters Π, and the
duplicated edges between vertices of two clusters can be removed if they represent the
same path in the splice graph. The distances of duplicated edges may differ by at most
2γ bases, but the minimum weight of all the duplicated edges will be assigned to the
only edge kept in the compressed flow network. The capacity of each vertex changes
to the size of the cluster, and the capacity of an edge is the number of duplicated
edges in the original flow network. Therefore, γ adjusts the degree of heterogeneity of
reads in each clusters.When γ goes larger, generally more reads on the same exon can
be grouped into one cluster and more reads containing the same splice junctions can
also be clustered together. As a result, the compressed flow network has less vertices
and edges and its size will become closer to that of the splice graph. In practice,
γ is set to half the expected fragment length, γ = len(r)/2, which improves speed
by significantly reducing the size of the flow graph while retaining high accuracy by
allowing sufficient overlaps among reads in a cluster.
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The calculation of partition can finish in O(|V |) time. Our simulation studies
have demonstrated that the compression may greatly reduce the time cost while
maintaining a satisfactory accuracy of the assembled transcript copies.
4.6 Consolidating transcript reconstruction across alternative splicing
events
The alternative splicing events (ASEs) happening between two cluster vertices will
lead to more than one ways to connect them. In presence of multiple ASEs, it is
important to avoid a simple enumeration of all possible isoforms from the combina-
tions of variants in the ASEs. Therefore, we leverage the reads that span multiple
ASEs to help evaluate the likelihood of existence of a possible isoform, using the
MultiSplice features developed in our previous work [Huang et al., 2012]. Formally,
a MultiSplice is a sequence of adjacent exons on a path of the splice graph, such that
reads longer than a particular length may span all these exons. These features are
calculated and incorporated here to reduce the possibility of linking the vertices into
false transcripts.
Let e denote an edge in the compressed flow network. Let b denote the MultiSplice
feature that consists of the same set of exons as the path indicated by e. Let ψ(b)
denote the size of the sampling window of b [Huang et al., 2012], which is the number
of positions that a read could fall on in order to cover all exons of b (Figure 4.4). If
no read is observed spanning b, the existence of edge e cannot be confirmed. In this
case we assign a penalty to the weight of e by calculating the probability of observing
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e
MultSplice b)(bψ r
Figure 4.4: An example of a MultiSplice feature. Two ASEs (both are exon-skipping)
reside between the clusters π1 and π2. The feature b consists of 5 exons on the path
indicated by edge e. Two possible alignments of read r are shown in order for r to
span b and confirm the existence of edge e. The possible positions of such alignments
then give a sampling window of b (the window bounded by the two light blue lines).
no spanning read,
P (e not confirmed) =
(
1− ψ(b)
len(e)
)|ce|
, (4.7)
where ce is the capacity on e. If ψ(b) = 0, no read may span b at the given read
length, P (e not confirmed) = 1. Thereafter, we adjust the weight of e by adding
− logP (e not confirmed) to w(e).
4.7 Experimental results
We compared the performance of our method Astroid with four other state-of-the-
art approaches for transcript reconstruction, including two “genome-guided” meth-
ods [Garber et al., 2011b] with different heuristics, Cufflinks [Trapnell et al., 2010b]
and Scripture [Guttman et al., 2010] (Cufflinks 2.0.2 and Scripture beta version 2
were downloaded, Cufflinks was run in the mode that carries out both reconstruc-
tion and quantification and without -g/-G option), one representative method for
Lasso-based “genome-guided” assembly IsoLasso [Li et al., 2011b] (IsoLasso version
2.6.0) and one “genome-independent” approach Trinity [Grabherr et al., 2011] (Trin-
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ity version 2012-10-05). The assembled transcripts from Trinity were generated in
fasta format and were mapped to the reference genome using BLAT [Kent, 2002] with
default parameters. Only hits with complete match were considered in the compar-
isons. To understand the sensitivity and specificity of the transcript reconstruction
as well as the accuracy of transcript quantification, we first did comparison on all
five approaches using simulated datasets of varying sampling depths. We then com-
pared the genome-guided assembly methods (Trinity excluded) on two real RNA-seq
datasets, MAQC data[Shi et al., 2006] and Alexa-seq data[Griffith et al., 2010], where
qPCR of a subset of transcripts are available to assess the accuracy of quantification
using RNA-seq.
4.8 Simulation Studies
4.8.1 Data Simulation
We developed a simulator that mimics a real RNA-seq experiment and generates
fragments from provided transcript copies. The simulation process consists of three
steps: (1) Build a synthetic transcriptome by randomly assign copy numbers to all
the genes and isoforms in the annotation database and set this as the true profiles. (2)
Randomly cut the transcripts in the synthetic transcriptome into small fragments and
dynamically check the lengths of the generated fragments. Fragments with lengths
in a certain range (e.g. [150bp, 350bp]) are selected with probability to construct
the sequencing library. This step stops when the number of fragments in the library
exceeds the pre-specified sequencing depth. (3) 2×75bp paired-end reads are sampled
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from both ends of these selected fragments.
4.8.2 Matching Criteria
We evaluate the assembly results using similar criteria proposed in IsoLasso [Li et al.,
2011b]. The assembled transcripts are compared with all the expressed transcripts
in the profile (referred as “reference transcripts”). Two multi-exon transcripts are
considered matched if they satisfy that (1) they contain the same set of exons; (2)
all the exon boundary coordinates are identical except the start of the first exon
and the end of the last exon. Also, two single-exon transcripts match if and only if
at least 50% of the exons are overlapped. We adopted sensitivity and precision to
measure the accuracy of the assembly results. Let M denote the number of reference
transcripts. N out of M ′ assembled transcripts can be matched to the reference
transcripts. Hence, sensitivity = N
M
, and precision = N
M ′
.
4.8.3 Quantification Accuracy Criteria
Both Cufflinks and IsoLasso quantify transcript expression in the unit of FPKM. In
Astroid, we use eTPM. However, these measurements cannot be directly compared.
Therefore, we evaluate the quantification accuracy by the correlation between the
transcript abundances estimated by each method and the true profiles. Pearson
correlation [Bohnert and R., 2010] is adopted for this assessment. Let Y denote the
true copy numbers of the transcripts and Ŷ denote the estimated abundance. The
correlation is calculated as r(Y, Ŷ ) = cov(Y, Ŷ )/(σY · σŶ ), giving a value between −1
and +1. Higher correlation indicates more accurate estimation results.
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4.8.4 Results
We conduct our first experiment to compare the performance of different methods
on the transcriptome level. 30 million 2×75bp paired-end reads (insert size around
250bp) were simulated from the human transcriptome using RefSeq transcripts anno-
tation. According to the profile, 18,374 transcripts from 13,030 genes were expressed.
The reconstructed full-length transcripts of each method were matched against the
ground truth, then the sensitivity and precision were assessed against different gene
expression quantiles.
As shown in Figure 4.6 (a), Astroid consistently acquired highest sensitivity with
increasing gene coverage. Even for the lowly expressed genes (bottom 10%), Astroid
successfully recovered around 95% of these transcripts which is more than at least
20% of all the other methods. The precision of Astroid also outperformed the others
on the bottom genes (shown in Figure 4.6 (b)). As gene expression climbs, the
precisions became comparable between Astroid and Cufflinks, but were smaller than
that of IsoLasso. This is probably related to the shrinkage strategy taken by IsoLasso
which eliminates a large portion of transcripts through Lasso [Tibshirani, 1996].
Figure 4.6 (c) illustrates the quantification accuracy of each method. Astroid
achieved highest correlation across different gene expression and demonstrated its
ability of highly precise quantification through directly assembling transcript copies.
However, both Cufflinks and IsoLasso showed very poor estimation. A further inves-
tigation on Cufflinks and IsoLasso abundance estimation results revealed that they
both provided extremely high FPKM for short transcripts (less than 300bp) which
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Table 4.2: Summary statistics of each method with various sampling depths. Corre-
lation values in parentheses are calculated on only long transcripts (length > 300bp.
Methods
sensitivity
10M 20M 30M
Astroid(γ=0) 79.28% 91.71% 94.30%
Astroid(γ=30) 79.20% 91.76% 94.22%
Astroid(γ=50) 79.08% 91.64% 93.87%
Cufflinks 49.43% 74.48% 81.50%
IsoLasso 2.86% 23.97% 45.83%
Scripture 38.51% 62.13% 74.04%
Trinity 3.36% 13.01% 23.04%
Methods
precision
10M 20M 30M
Astroid(γ=0) 51.44% 80.23% 86.61%
Astroid(γ=30) 51.31% 80.01% 86.28%
Astroid(γ=50) 51.18% 79.47% 85.78%
Cufflinks 51.31% 75.75% 79.55%
IsoLasso 19.83% 75.26% 85.81%
Scripture 12.46% 26.34% 39.74%
Trinity 1.74% 6.13% 12.32%
Methods
correlation (long transcripts only)
10M 20M 30M
Astroid(γ=0) .805 (.801) .870(.868) .922(.919)
Astroid(γ=30) .808(.805) .872(.869) .918(.914)
Astroid(γ=50) .808(.806) .874(.870) .912(.919)
Cufflinks .106(.631) -.033 (.773) -.018(.808)
IsoLasso -.027 (.356) 0.116 (.559) .011 (.755)
Scripture N/A N/A N/A
Trinity N/A N/A N/A
is quite inconsistent with the profile. Similar observation was also reported by Li, et
al. [Li and Dewey, 2011]. Excluding the abnormal results on these short transcripts,
the correlation increases for both methods, but still falls behind Astroid. Astroid,
however, was not heavily affected by the length of transcripts because of its capability
to explicitly model the distance between reads and transcription start and termination
sites.
We also look into the effect of the compression parameter on Astroid. According
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Figure 4.5: Performance comparison by Astroid with 3 different compression pa-
rameters (0bp, 30bp and 50bp), Cufflinks, IsoLasso, Scripture and Trinity on the
synthetic human transcriptome dataset. (a), (b) and (c) are the sensitivity, precision
and correlation (excluding Scripture and Trinity) against increasing gene coverage
when the mean sequenced fragment length is 350bp. (d), (e) and (f) are the sensi-
tivity, precision and correlation (excluding Scripture and Trinity) against increasing
gene coverage when the mean sequenced fragment length is 450bp (The legends of
these three subfigures are the same as (a), (b) and (c), respectively).
Table 4.3: Computational performance on there 30M 2×75bp paired-end datasets
with different mean fragment lengths. All programs were run on an Intel Xeon E5-
2450 32-core 2.10 GHz Linux server with 98GB of RAM.
Methods 250bp 350bp 450bp
Astroid(γ = 0) 24h 10h 4h
Astroid(γ = 30) 7h 6h 1h
Astroid(γ = 50) 1h 1h 40min
Cufflinks 40min 38min 30min
IsoLasso 10min 5min 4min
Scripture 15min 16min 18min
Trinity 8h 7h 6h
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Figure 4.6: Performance comparison of Astroid with 3 different compression parame-
ters (0bp, 30bp and 50bp), Cufflinks, IsoLasso, Scripture and Trinity on 30M 2×75bp
(insert size around 250bp) paired-end dataset. Evaluation measurements were plot-
ted against different gene expression quantile (in 10% increments). (a) Each point
in the plot represents the sensitivity of one method which is the ratio between the
number of matched transcripts and the reference transcripts within one quantile. (b)
Each point represents the precision of one method which is the number of matched
transcripts and the total assembled transcripts within one quantile. (c) The correla-
tion of transcript expression is computed on the set of matched transcripts for each
method.
to the results shown in Figure 4.6, we do observe that Astroid baseline (γ = 0bp)
performs better than the other two with positive γ, but the difference is not that
significant. Meanwhile, as shown in Figure 4.3, the time cost improves from 1 day to
1 hour as γ increases from 0bp to 50bp. This suggests that significant improved in
efficiency can be achieved without much degradation of its performance. Therefore,
in real practice, we may set the compression parameters at a comparably larger value
(γ = len(r)/2). We use this setting in real data experiments.
We next evaluate how the sampling depth may affect the performance of each
method. To do this, we first sample 10M and 20M 2×75bp paired-end reads by
random selection out of the 30M dataset. Table 4.2 shows the overall sensitivity, pre-
cision and correlation on these three datasets. From the statistics, we see that both
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the sensitivity and precision improve for all methods as more reads are sequenced.
Apparently, higher sampling depth is more conducive for inferring transcript struc-
tures. Similar with previous observation, Astroid showed best performance against
various sampling depths, which indicates that eTPM computed from the effective
transcripts, is a robust measure for estimating the relative transcript abundance.
Table 4.4: Summary statistics on two 30M 2×75bp paired-end datasets, with mean
insert size of 350bp and 450bp respectively.
Methods
350bp
sensitivity precision correlation (long)
Astroid(γ = 0) 95.23% 88.85% .923(.919)
Astroid(γ = 30) 95.18% 88.60% .919(.915)
Astroid(γ = 50) 95.05% 88.52% .914(.910)
Cufflinks 78.53% 81.97% 0.089(.682)
IsoLasso 37.47% 81.04% .011(.730)
Scripture 64.97% 34.19% N/A
Trinity 19.61% 9.60% N/A
Methods
450bp
sensitivity precision correlation (long)
Astroid(γ = 0) 95.48% 89.97% .929(.925)
Astroid(γ = 30) 95.47% 89.83% .927(.923)
Astroid(γ = 50) 95.35% 89.69% .923(.919)
Cufflinks 71.59% 75.57% .086(.601)
IsoLasso 28.95% 68.75% −0.022(.618)
Scripture 58.14% 23.76% N/A
Trinity 11.85% 5.25% N/A
Besides sampling depth, we also investigate how varying fragment lengths would
affect the performance of each method. Table 4.4 show the summary statistics on
two 30M paired-end datasets with mean insert size of 350bp and 450bp, respectively.
Combining with the results shown above on the 30M dataset with mean insert size
of 250bp, we see that the performance of Astroid, especially the precision, improves
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Figure 4.7: (a). Venn Diagram of qRT-PCR validated transcripts reconstructed
by Astroid, Cufflinks, Scripture and IsoLasso. (b)-(d) Scatter plots (on loge scale)
of transcript abundance estimated by Astroid, Cufflinks and IsoLasso, respectively,
against qRT-PCR expression on the set of qRT-PCR validated transcripts that are
reconstructed in full length by each method.
as the the fragment length increases. This demonstrates Astroid’s capability of tak-
ing advantage of longer fragments to infer the true set of transcripts. Moreover, the
correlation computed between the true profiles and the estimated abundance of the
matched transcripts of Astroid is much higher than those of Cufflinks and IsoLasso,
suggesting that the eTPM estimated by Astroid provides a more accurate quan-
tification of transcript quantities. Figure 4.5 also demonstrated Astroid’s superior
performance over the other existing methods on varying fragment lengths datasets.
4.9 Experiments with real RNA-seq datasets
4.9.1 MAQC data study
For evaluation on real RNA-seq experiments, we first compared the four genome-
guided transcript reconstruction approaches Astroid, Cufflinks, Scripture and Iso-
Lasso using the RNA-seq dataset from Microarray Quality Control (MAQC) project
Human Brain Reference (HBR) sample [Shi et al., 2006] (NCBI Short Read Archive
accession number SRA012427). This dataset contained 23 million 2x50bp paired-end
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reads generated from three lanes. Besides RNA-seq data, 907 transcripts were an-
alyzed with TaqMan qRT-PCR for their expression, including 893 that could be
matched to RefSeq transcript annotation [Pruitt et al., 2008] (accession number
GSE5350). We focused our analysis on this subset of validated transcripts.
Among the 893 qPCR-validated transcripts, Astroid correctly reconstructed 227,
with a sensitivity of 25.42% (227 out of 893). This sensitivity is higher than those of
Cufflinks (20.04% or 179 of 893) and IsoLasso (15.79% or 141 of 893). This demon-
strates Astroid’s good ability to reconstruct full-length transcripts. The venn diagram
shown in Figure 4.7 (a) illustrated a good consistency of their assembly results. We
notice that Scripture reconstructed the most number of validated transcripts (44.12%
or 394 of 893). This is due to the strategy of Scripture which tries to enumerate all
possible transcripts given the exons and junctions observed from RNA-seq data. This
strategy may highly increase the sensitivity but it also introduces large amount of
false positives, especially on the genes with high coverage. In fact, the total number
of assembled transcripts is 92,977 for Scripture which corresponds to a precision of
0.42% (394 of 92,977) and it is only half of Astroid (0.87% or 227 of 26,119). How-
ever, it is surprisingly that both Cufflinks and IsoLasso showed lower precision than
Scripture on the identification of validated transcripts: 0.26% (179 of 69,011) and
0.10% (141 of 135,085). A close examination revealed that majority of their recon-
structed transcripts are very short single-exon transcripts with low coverage, which
are probably just background noises due to sequencing or mapping biases.
Next, we examined the transcript expression measured by qRT-PCR experiments
and the expression estimated by each method (excluding Scripture) on the set of
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transcripts that were validated and correctly reconstructed: scatter plots are shown
in Figure 4.7 (b)-(d). Transcript abundance inferred by Astroid reached a Pearson
correlation as high as 0.853 on all the transcripts it correctly assembled, slightly
higher than Cufflinks (0.839) and much higher than IsoLasso (0.699).
This result demonstrated that Astroid is competitive for transcript quantifica-
tion. We further ran Cufflinks in its quantification-only mode by providing the Ref-
Seq transcript annotation. The estimated transcript abundance by Cufflinks on all
893 validated transcripts had a Pearson correlation of 0.866, consistent with its pre-
vious reports on MAQC dataset for transcript quantification [Roberts et al., 2011].
The difference between Cufflinks without transcript annotation and with annotation
suggests that downstream analysis such as transcript quantification can be signifi-
cantly altered by transcript reconstruction results. On the other hand, Astroid shows
the prominent ability of discovering the underlying transcripts and providing reliable
expression estimates simultaneously.
4.9.2 Alexa-seq data study
We further applied Astroid and other methods to a real RNA-seq dataset used
by Alexa-seq [Griffith et al., 2010], an alternative expression/transcription analy-
sis method. Total 262 million Illumina paired-end RNA-seq reads (36bp or 42bp)
were generated from two cell lines: fluorouracil (5-FU)-resistant and -nonresistant
human colorectal cancer cell lines, MIP101 and MIP/5-FU. The raw RNA-seq reads
were downloaded from Alexa-seq website (http://www.alexaplatform.org/alexa_
seq/). 167 million paired-end reads were generated from MIP101 sample and 89.82%
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Table 4.5: Summary statistics on the validated set of exons.
Methods
# exons reconstructed correlation with qRT-PCR expression
MIP101 MIP/5-FU MIP101 MIP/5-FU
Astroid 137 114 0.99 0.81
Cufflinks 124 66 −0.02 −0.03
IsoLasso 131 76 0.99 0.87
Scripture 105 60 N/A N/A
of them were successfully mapped by MapSplice using human hg18 reference genome.
The rest 95 million reads came from sample MIP/5-FU, among which 90.26% were
mapped by MapSplice. Alexa-seq also provided qRT-PCR validation on 192 alterna-
tively expressed exons. We focus the comparison of all the methods on identification
of all the validated exons. One exon is considered reconstructed by one method
if: (1) at least one assembled transcript contains this exon; (2) both boundaries of
the identified exon have to match the hg18 annotation unless this exon is transcrip-
tion start/end; (3) if the exon is transcription start/end, only downstream/upstream
boundary of this exon is required to match the annotation, respectively. The esti-
mated abundance on this exon is collected as the cumulative estimated abundance
on the exon of all the transcripts assembled covering it.
Table 4.5 shows the number of validated exons successfully reconstructed and the
correlation between the estimation and the qRT-PCR expression by each method.
From the results, we observe that Astroid reconstructed the highest number of exons
in both samples among all the assembly tools. This suggests that Astroid successfully
reconstructed the transcripts containing these target exons. Meanwhile, correlation
between estimated abundance and qRT-PCR expression was computed on the set
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of reconstructed exons by each method. Astroid and IsoLasso acquired the highest
correlation (0.99) on sample MIP101, much higher than Cufflinks (−0.02). The corre-
lation by Astroid dropped on MIP/5FU sample, but was still comparable to IsoLasso,
which also outperformed Cufflinks.
Although Astroid consistently performs better than the other methods on the
two real RNA-seq datasets, it is noticed that its improvement is not as significant
as that in simulation experiments. After further investigation, we found that: (1)
for real datasets, we only have access to a very small set of validated transcripts
or exons supported by abundant read alignments. But for simulation, we sampled
reads from the whole transcriptome containing genes with a large dynamic range in
their expression. The splice junctions with relatively low read support tend to be
filtered out by methods like Cufflinks and IsoLasso, which lead to their failure in
reconstructing the correct set of full-length transcripts; (2) for MAQC dataset, the
transcripts with PCR validation are mainly from single-isoform genes. As we know,
it is easier to reconstruct and quantify single-isoform genes than multi-isoform genes.
As a result, the differences among these methods are minimal.
4.10 Discussion
In this chapter, we have presented a novel method Astroid for simultaneous transcript
reconstruction and quantification. Compared with existing methods which typically
reconstruct isoforms in a splice graph, our approach provides a unique solution by
piecing individual reads into a set of effective transcript copies. A novel measure for
transcript abundance eTPM has also been defined based on the assembled effective
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copies, rather than indirect estimators that fully depend on the read count. The
problem of the reconstruction of effective transcript copy has been modeled as a
minimum-cost flow problem, which allows the solution of a maximum-likelihood set
of copies.
We evaluated Astroid as well as four existing methods using both simulated data
and real data. In general, the eTPM measure generated by Astroid has a better
overall correlation with the ground truth or qRT-PCR measurement than FPKM
output from Cufflinks and Isolasso. However, further validations using real datasets
are still necessary in checking out the relationships among eTPM, TPM and FPKM
in terms of their accuracy in inferring the abundance of alternative transcripts in
multi-isoform genes as well as reconstructing isoforms of genes with relatively low
expression. We are also interested in validating whether eTPM or TPM would be
able to effectively normalize transcript abundance by the size of transcript library that
is sample-specific, alleviating the risk of comparing transcriptoms with drastically
different transcript composition.
Our approach is built on the assumption that short read sequencing may only
capture a fraction of each mRNA molecule. Hence, the sampling “gaps” on tran-
scripts that we have modeled has the potential to handle uneven read distribution
due to various biases, such as positional bias and sequence bias. Ill-formed copies
which contain only a proportion of the expected transcript may indicate an aberrant
distribution of the observed reads and suggest possible biases. For example, if 3’ end
positional bias is observed, we may compensate the less sequenced 5’ end by allowing
a larger gap between 5’ end and one fragment. We are currently working on potential
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methods to correct these biases within the existing framework.
Copyright c© Yan Huang, 2015.
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Chapter 5 Transcriptome analysis on large-scale RNA-seq datasets
5.1 Introduction
The RNA-seq technologies which sequence the mRNA transcriptome at an unprece-
dented level have enabled a more comprehensive analysis of the presence and quantity
of the mRNA transcripts in the transcriptome. However, only examining one individ-
ual or limited number of samples may not reveal the overall picture of cell function-
ing, development and differentiation. Take cancer study for example, every tumor
is different. The sample size is the key to understanding of the genetic mechanisms
behind various diseases, and therefore crucial for precise disease diagnosis, prognosis
and treatment.
Figure 5.1: Typical cost of sequencing a human-sized genome, on a logarithmic scale.
The curve decreases much faster than Moore’s law [Moore, 1965]. Figure accommo-
dated from Wikepedia( www.wikepedia.com)
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Nowadays, with the rapid development of sequencing technology, we are able to
sequence a sample or tissue with much cheaper cost, which directly leads to the
capability of sequencing much more samples with same budget. Figure 5.1 illustrates
that now the cost of sequencing a human-sized genome has dropped to $100, 000
by 2009 and $1, 000 by 2014. Empowered by this advancement, several large-scale
genome sequencing projects have launched to accelerate the understanding of the
molecular basis of human diseases, especially cancer, such as ICGC (International
Cancer Genome Consortium), TCGA (The Cancer Genome Atlas) and CCLE (The
Cancer Cell Line Encyclopedia). For example, the RNA-seq data of TCGA consists
of approximately 5000 samples, more than 1 trillion reads and approximately 50
TeraBytes of binary files. The big data have brought great challenges of insight
discovery and process optimization beyond computing and storage resources. In this
chapter we will elaborate the computational difficulties and introduce the standard
Cufflinks+Cuffmerge pipeline for processing massive RNA-seq data along with its
problems. Lastly, we will present an alternative workflow which aims at resolving
the issues with previous approaches. It performs comparative transcriptome analysis
across hundreds of RNA-seq samples and efficiently discovers the biological signatures.
5.1.1 Computational challenges in studying cancer transcriptomes
Heterogeneity between tumors and even within tumor has been hindering therapy [Hi-
ley et al., 2014, Fisher et al., 2013, Junttila and de Sauvage, 2013]. To understand the
mechanism of cancer in a molecular level, cancer consortiums such as TCGA [TCG]
and ICGC [ICG] have generated a comprehensive set of next generation sequenc-
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ing (NGS) data on thousands of patient samples. With whole genome sequencing
data, much progress has been made on uncovering genomic mutations that drive tu-
mor evolution [Network, 2012, 2013b, Network et al., 2013]. On the other hand, the
RNA-Seq data captures the snapshots of the entire transcriptomes with hundreds of
millions of short reads per sample in an unprecedented depth and resolution. The
alignments of these reads has made possible the discovery of novel splice variants,
gene fusions and expression signatures, among others. To date, the analyses on these
transcriptomes have largely been focused on gene expression patterns associated with
cancer subtypes [Network et al., 2013, Hoadley et al., 2014, Network, 2013b,a]. An-
other complexity yet remaining barely explored has been the regulation of alternative
splicings that differentiate the transcriptomes, which directly determines the variety
and quantity of transcript isoforms and ultimately the proteins. Disentangling this
transcription-level heterogeneity could further highlight misregulated or aberrant iso-
forms, especially those implicated as determinants of cancer subtype by exhibiting
subtype-specific presence or usage.
However, to compare hundreds of transcriptomes is not a trivial extension from ex-
isting differential expression/transcription analysis approaches. One specific challenge
in characterizing cancer transcriptome is the ability to discover and catalogue novel
cancer-specific events, many of which may be rare and may not be curated into ex-
isting annotations. A common practice in expression study, such as the pipeline that
processed most TCGA samples, feeds the reads into a reference transcriptome-based
program like RSEM [Li and Dewey, 2011] to quantify known isoforms (Figure 5.2b).
The estimated isoform abundance is then carried over to downstream analyses such
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as subtype classification and survival prediction. Unfortunately, this approach is
only confined to the isoforms within the reference transcriptome and simply ignores
aberrant transcription events.
To avoid the limitation of incomplete annotation, one often opts to use an ab
initio isoform reconstruction method to first infer isoforms from raw read alignments.
Tools such as Cufflinks and Scripture can be leveraged with partial or no help of
a-priori annotation. While this is promising for small data sets, a caveat could be
the scalability. Isoform reconstruction algorithms heavily depend on read alignments,
gapped alignments that reveal splice junctions in particular, which are not noise free
due to the length of the short reads coupled with the complexity of human genome.
Although current aligners such as MapSplice and TopHat are capable of controlling
the false junction discoveries, the set of total putative junctions can easily become
intractable when considering all samples in the data set. In TCGA BRCA data, for
example, on average the number of junctions in each sample is XXX with XX.
Another question remaining unsolved is how to use the power allowed by the
sample size. The aforementioned approaches process each sample independently,
from read alignment to isoform quantification. Given the wealth of the information
provided in the large datasets with hundreds of samples, this approach may not be
ideal. For example, splice junctions that are highly supported by read alignments in
some sample may be poorly supported in others due to random sampling. Processing
each sample independently may falsely eliminate any transcript missing a single splice
junction, resulting incomplete transcriptome, complicating comparison as well.
Cufflinks is widely used tool for transcriptome analysis. It has a comprehensive
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pipeline for transcriptome reconstruction, q In this chapter, we systematically inves-
tigate the effectiveness of Cufflinks pipeline for the joint analysis of massive RNA-seq
data.
Figure 5.2: Overview of different workflows for differential analysis on large-scale
datasets. a) Pipeline of proposed method. b) Typical TCGA pipeline guided by
transcrptome annotation using RSEM. c) Standard Cufflinks+Cuffmerge pipeline op-
tionally assisted by transcriptome annotation.
5.1.2 The TCGA breast cancer RNA-seq datasets
The Cancer Genome Atlas (TCGA) project was supported by National Cancer In-
stitute (NCI) and National Human Genome Research Institute (NHGRI) and its
fundamental goal is to improve our ability to diagnose, treat and prevent cancer.
Starting from 2006, it first aims at comprehensively mapping and characterizing the
genomic changes in brain and ovarian cancers, as well as proving that a national net-
work of researchers could effectively collaborate to generate large-scale genomic data
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and make discoveries. The achievements further led to more resources devoted for
characterization of more than 30 additional tumor types, including nine rare cancers.
The TCGA breast cancer (BRCA) consists of 819 RNA-seq samples. These sam-
ples constitute a large dataset with a total of 6 TeraBytes of data in binary format,
5-10 GigaBytes per sample. Every sample contains 120M to 250M 2×50bp paired-end
reads. These samples have also been clinically classified as normal (91) and tumor
(728), with 5 tumor subtypes determined by clinical characteristics and gene expres-
sion: Basal (123), HER2 (60), LumA (359), LumB (170) and normal-like (16). All
following analysis is performed on the TCGA BRCA RNA-seq dataset.
5.2 Existing pipelines on joint analysis of hundreds of cancer transcrip-
tomes
Consider the complexity and scale of the TCGA BRCA dataset, current analysis
usually rely on the prior knowledge of the annotated transcripts. There are mainly
two trends of pipelines within this category and they differ in the read mapping stage.
One first map the reads to the reference genome and then feed the read alignments
to quantification models, such as Cufflinks with annotation mode to estimate the
abundance of the reference genes/isoforms. The other one directly feeds the raw reads
into reference transcriptome-based program like RSEM which uses built-in Bowtie to
map the reads to the reference transcripts and then performs quantification. The
abundance of the known isoforms is measured in RPKM/FPKM [Trapnell et al.,
2010b] or TPM [Li et al., 2010a] and compared across samples. Both workflows
are employed by many research groups and institutions, such as UNC Chapel Hill
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and Broad institute. An obvious problem with this kind of approach is that by
restricting the analysis on the reference transcriptome, aberrant genetic events will
be overlooked, such as novel transcription and gene fusion.
To circumvent this problem, the other strategy doesn’t depend on known tran-
script database, and uses Cufflinks+Cuffmerge pipeline for reconstructing a unified
set of transcripts first (Figure 5.2c). Ideally, the “assembly-merge” model would work.
But in real application, the ambiguity is greatly enlarged for merging transcripts from
large number of samples and therefore largely complicates downstream analysis. In
this section, we will systematically study this pipeline and show its limitations on
large-scale data analysis.
Cufflinks is a comprehensive tool developed for mRNA transcriptome analysis
using RNA-seq data. Provided with RNA-seq read alignments, it has several com-
ponents: reconstruct isoform transcripts, quantify their abundances, and test for
differential expression and regulation in RNA-Seq samples. Figure 5.3 illustrates a
typical workflow of Cufflinks [Trapnell et al., 2010b]. Generally, when applied on
multiple RNA-seq samples, Cufflinks first treats each sample independently and per-
forms assembly and quantification analysis, Cuffmerge then collectively combines all
individual results for further study.
5.2.1 Cufflinks running modes
Cufflinks is a powerful tool which provides multiple options allowing for user cus-
tomized running modes. Table 5.1 summarizes two different assembly modes of Cuf-
flinks: with and without guidance of annotated transcripts. The RABT assembly
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Figure 5.3: Overview of the Cufflinks workflow. The raw RNA-seq reads are first
mapped to the reference genome using alignment tools such as Tophat [Trapnell
et al., 2009c] or MapSplice [Wang et al., 2010a]. Cufflinks assembles the RNA-seq
read alignments into a parsimonious set of transcripts, and then estimates the relative
abundances according to a maximum likelihood model that assigns probability for
each fragment to one transcript. In need of comparing multiple transcriptomes of
different conditions, Cuffmerge is utilized for first merging the transcript assembly
result of each individual sample. Following this, Cuffdiff takes input of the merged
set of transcripts and the read alignments from all groups of samples, and tests for
significant changes in gene/isoform expression, splicing and promoter use.
which refers to the annotation will include reference transcripts with no read cover-
age for completeness. Please note that “-G /ref.(gtf/gff)” is different from RABT
assembly. It is quantification-only mode of Cufflinks which is used for estimate the
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abundance of known gene isoforms. Table 5.2 summarizes four modes of Cuffmerge.
Cuffmerge is designed to compare multiple assemblies, remove duplicates and au-
tomatically filter the transcripts that are probably artfifacts. Reference transcripts
or/and reference DNA sequences may be fed to Cuffmerge to maximize overall as-
sembly quality.
Table 5.1: Two modes of Cufflinks assembly. RABT assembly is guided by
gene/isoform annotation. The reference transcripts are tiled with faux reads which
are also combined with sequencing reads for transcript reconstruction. The assembled
transcripts are further compared with the reference to determine whether they are
sufficiently novel.
Mode Type Option Mode description
Cufflinks w/o annotation N/A
Assemble transcripts solely
from read alignments
Cufflinks assisted by annotation
RABT assembly
−g/ref.(gtf/gff) Reference transcripts are required to
provide additional information
Table 5.2: Four modes of Cuffmerge. Reference transcripts or reference genome can
be provided to Cuffmerge for guidance.
Mode Type Option Mode description
Cuffmerge N/A
Merge transcripts solely
from the input assemblies
Cuffmerge assisted by
reference transcripts
−g/ref.gtf The input assemblies are merged
together with the reference GTF
Cufflinks assisted by
reference sequence
−s/ref.seq The input assemblies are merged
guided by the reference genome
Cufflinks assisted by
reference transcripts&sequence
−g/ref.gtf&− s/ref.seq Combine “-g/ref.gtf” and “-s/ref.seq”
5.2.2 Cufflinks investigation experiments
Using 819 RNA-seq datasets from TCGA BRCA project, we conducted analysis on
Cufflinks pipeline. Following the workflow shown in Figure 5.3, we first ran Cufflinks
assembly in both modes on each individual sample. Next, Cuffmerge in four modes
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were applied on the two group of assemblies to merge the reconstruction results into
a single gtf. Our first experiment is to compare two assembly modes of Cufflinks.
Comparison of Cufflinks without annotation and RABT assembly. Both
Cufflinks without annotation and RABT assembly were ran on all 819 RNA-seq
samples of TCGA BRCA project. We would like to compare the similarity of two
modes on each individual sample. Cuffcompare was utilized for this task. As stated
in Cufflinks manual, Cuffcompare “examines the structure of each the transcripts,
matching transcripts that agree on the coordinates and order of all of their introns,
as well as strand. Matching transcripts are allowed to differ on the length of the
first and last exons, since these lengths will naturally vary from sample to sample
due to the random nature of sequencing.” It will generate a union of all transcripts
from both inputs and report whether or not each transcript is present in the input
assemblies.
Figure 5.4(a) summaries the count of isoforms from different origin in the Cuf-
fcompare union set. We observe that the shared portion is much less than the
unique ones for most samples and the RABT assembly mode generates much larger
set of isoforms than the without annotation assembly. This result indicates that
there exists large discrepancy between these two assembly modes. Figure 5.4(b)
also supports this discovery. The percentage of shared isoforms is computed as:
#shared isoforms
#isoforms in Cufflinks w/o annotation
×100% and #shared isoforms
#isoforms in RABT assembly
×
100% for two modes, respectively. Clearly, RABT assembly produces significantly
more isoforms than without annotation mode in most samples.
From these results, we found out that different modes of Cufflinks gave very
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different results. Therefore, transcript level reconstruction remains very challenging
and difficult.
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Figure 5.4: (a) For each sample, the counts of isoforms shared by both Cufflinks
assembly modes and unique to only one mode are plotted. Each bar represents one
sample and each color represents one origin of the isoforms. (b)Histogram of percent-
age of shared isoforms reconstructed by two Cufflinks assembly modes respectively.
Comparison between individual assembly and Cuffmerge result. Fol-
lowing Cufflinks assembly, Cuffmerge is applied to merge all assemblies into a single
transcript set for further analysis. In this section, we would like to study the effec-
tiveness of Cuffmerge. To achieve this goal, we combine the 819 RABT assembly
results using Cuffmerge with “-gs” option and compare the merged result with each
individual assembly. Because both RABT assembly mode and Cuffmerge with “-gs”
option are assisted by references which leads to more power of filtering artifacts.
Figure 5.5 shows a histogram of percentage of shared isoforms in Cuffmerge result.
We see the percentages are fallen in a very narrow range, approximately between
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15.5% and 17.0%. This plot illustrates (1) very small portion of isoforms in the
merged set matches to each individual sample, and (2) the percentages of shared
isoforms are quite similar across the samples. Figure 5.8 also supports this finding
which shows that there is a large number of isoforms in the merged set that aren’t
originated from one specific sample and Cuffmerge also throws away some isoforms
it regards as “artifact” for every sample.
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Figure 5.5: Histogram of percentage of shared isoforms in Cuffmerge result.
We further look into the isoform count composition within each sample (Fig-
ure 5.6a). Similar with previous observation, the numbers of shared isoforms with
merget set are highly consistent across samples. Figure 5.6b shows a histogram of
the percentage of isoforms discarded by Cuffmerge. For most samples, less than 2/3
of the isoforms are absent from the final merge set, probably due to some filtering
based on the reference transcripts and reference genome.
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Figure 5.6: (a) For each sample, the counts of isoforms shared by by both individual
sample and the merged set, and unique to only the sample (absent from the final
merged result) are plotted. Each bar represents one sample and each color represents
one origin of the isoforms. (b) Histogram of percentage of isoforms absent from
Cuffmerge result in each sample.
Since the shared portions of isoforms are highly consistent across the samples, pair-
wise comparison is conducted on the shared transcripts between any two samples. The
similarity distance between assemblies i and j is calculated as
#shared isoforms
#union isoforms of i and j
.
Here we only consider the isoforms present in the merged set. The heatmap shown
in figure 5.7 illustrates the average similarity between any two samples is around 0.9.
In conclusion, although individual assemblies may be quite similar between each
other, uncertainty of transcript reconstruction in each sample can be largely amplified
and propagated when looking at the entire data set: the merged set still has a lot of
transcripts than one can not find within one individual sample.
Comparison of Cuffmerge results. Besides the study on each individual sam-
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Figure 5.7: Heatmap comparing pairwise similarity among RABT assemblies. Only
the shared isoforms with Cuffmerge result are considered. Darker color means higher
similarity. Please note only 499 samples are included in the plot, since Cuffcompare
is limited to 500 inputs and one is reserved for merged set.
ple, we further look into the consistency among the merged assemblies. Totally 8
different assemblies can be obtained from merging two groups of Cufflinks assem-
bly. We denote them as: merged, merged opt g, merged opt s and merged opt gs for
the merged results from Cufflinks assembly without annotation, and rabt.merged and
other three with prefix “rabt.” for Cufflinks RABT assembly. Here, “ opt” is adopted
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Figure 5.8: For each sample, the counts of isoforms shared by both individual sample
and the merged set, and unique to either one are plotted. Each bar represents one
sample and each color represents one origin of the isoforms.
to distinguish various Cuffmerge options. For example, “ opt gs” indicates both ref-
erence transcripts and reference genome are provided.
Table 5.3 shows some summary statistics we collected from the merged assemblies
and the UCSC hg19 reference transcripts set. From this table we observe that the
number of genes and isoforms produced varies quite much among all 8 modes and
they both differ significantly from the reference. Moreover, although it is mentioned
in Cufflinks manual that the reference transcripts or reference genome can be in-
troduced in Cuffmerge for filtering artifacts, the total number of isoforms generated
are much higher when reference transcripts are fed. Besides this, the statistics be-
tween Cufflinks without annotation and RABT assembly are quite similar if of same
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Cuffmerge mode.
Table 5.3: Summary statistics collected for all Cuffmerge results and UCSC hg19
annotation.
Method hg19 merged merged opt g merged opt s merged opt gs
#genes 43, 925 181, 136 122, 668 83, 822 56, 153
#isoforms 376, 482 252, 015 383, 844 143, 569 311, 363
#isoforms
per gene
8.57 1.39 3.13 1.71 5.54
Method rabt.merged rabt.merged opt g rabt.merged opt s rabt.merged opt gs
#genes 238, 520 118, 092 93, 212 51, 666
#isoforms 258, 934 384, 934 106, 818 312, 682
#isoforms
per gene
1.09 3.26 1.15 5.05
To discover more of the pairwise consistency among all 8 merged assemblies, a dis-
tance matrix is computed. Similar with previous study, the similarity score between
two modes i and j(could also be hg19 reference) is defined as:
#shared isoforms
#union isoforms from i and j
× 100%
. The heatmap showed in Figure 5.9 is plotted according to this distance matrix. We
see that although the statistics are quite comparable, actually very little similarity
exists between Cufflinks without annotation and RABT assembly. But within each
assembly mode group, the Cuffmerge results with reference transcripts are approxi-
mately consistent with each other: a similarity score around 0.8 can be observed from
heatmap of option “-g” and “-gs”.
In summary, great ambiguity rises when merging transcripts from large number
of samples. Different options gave very different results, and the effect of each option
is difficult to predict.
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Figure 5.9: Heatmap comparing similarities among Cuffmerge results and UCSC hg19
annotation. Darker color means higher similarity.
5.2.3 Summary
In this section, we have investigated Cufflinks with 2 assembly modes and Cuffmerge
with 4 assistance options. The comparison experiments have demonstrated that dif-
ferent modes of Cufflinks and Cuffmerge will yield very different results. The incon-
sistency among diverse Cufflinks+Cuffmerge pipelines would introduce great ambi-
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guity and difficulty for downstream analysis, such as Cuffdiff which takes input of
the merged transcript set for differential transcription analysis. Moreover, although
the assemblies of each individual sample look very much alike, uncertainty of tran-
script reconstruction can be largely amplified when one tries to acquire the union of
the entire assembly result. The merged set produced by Cuffmerge has considerable
discrepancy with one sample.
Therefore, in general, although Cufflinks+Cuffmerge is a powerful pipeline that
can be extended to the application on large-scale datasets, the complexity of the data
and the uncertainty of the program could make the analysis intractable.
5.3 An ab initio method for the detection and visualization of differential
transcription on large-scale dataset
Despite the shortages mentioned above, reconstruction and quantification of full-
length transcripts are challenging problems due to the inadequate read length and
sampling depth. The unidentifiability problem exists where no unique solution may
exist for quantifying genes with multiple isoforms.
To circumvent all these problems of existing pipelines, we have developed a
pipeline that performs comparative transcriptome analysis across hundreds of RNA-
seq samples through a unified splice graph. This pipeline provides an ab initio method
for the detection and visualization of differential transcription without the knowledge
of transcript and/or gene annotations (Figure 5.2a). Our method describes a scal-
able approach to perform differential splicing analysis on large-scale (TBs and up)
data. The input BAM files are first pre-processed locally to allow distributed data
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storage. The processed expression information, in much reduced size and complexity,
is collected from every sample and pooled to initiate the DiffSplice algorithm [Hu
et al., 2012]. All samples are handled together in the analysis, as enabled by the uni-
fied expression-weighted splice graph (ESG). This could benefit difficult tasks such
as junction filtering and transcript reconstruction by leveraging overall statistics of
the whole data set. In comparison, the TCGA default RSEM pipeline Figure 5.2b
and Cufflinks pipeline Figure 5.2c both handles each sample separately. The RSEM
pipeline relies on a fixed transcriptome annotation and will discard novel isoforms.
The Cufflinks pipeline, though performing quantification procedure on a consensus
transcript set merged over all samples, essentially reconstructs transcripts for each
sample individually.
Our work addresses challenges of large scale RNA-seq data analysis with the fol-
lowing improvements: (1) computational efficiency capable of detecting novel tran-
scription variants and scalable with increasing sampling depth and rocketing number
of samples, (2) accurate splice graph construction through joint analysis of all samples:
The splice graph catalogues the set of exonic structures as well as high confidence al-
ternative splicing events. We propose a junction classification method where putative
junctions are classified based on their collective appearances from all samples. This
allows us to remove false positive junctions with insufficient or inconsistent occur-
rence; (3) accurate differential splicing identification at the alternative splicing level:
The splice graph provides a central reference for the mega-transcriptome. Each sam-
ple becomes an instance of the splice graph parameterized by its own expression at
the splice graph features. To avoid the uncertainty of full length transcript inference,
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the comparison between samples is done in the splice graph level by examining the
difference of expression at the alternative splicing sites.
5.3.1 Method
To efficiently handle hundreds of samples that are terabytes in size, we have created
a pre-processing step to condense the raw alignments (BAM files) into a much suc-
cinct format that is both effective and efficient for downstream analysis or reanalysis.
Evey read alignment is split into exonic segments that represent continuous sequences
covered by the reads and splice junctions that connect the exonic segments. Same
entries, such as same splice junctions and exonic segments that cover a same short
exon, are merged into one entry, associated with the count of its total presence. This
compact count table requires only 15% of the size of the original data and allows fast
reanalysis under one day for over 800 samples, yet maintains any necessary expression
information for calculating the read distribution of the corresponding sample. Be-
cause each sample is processed individually, this procedure can be easily parallelized
and accommodated to a distributed setup where the amount of data to be transferred
and actively kept needs to be minimized. For the same reason, upon increase of data
set, only the newly added samples need to be processed to facilitate a fast reanalysis.
Instead of independently reconstructing the transcriptome for every individual
sample, our pipeline pools information from all samples first and establishes a unified
structure of transcription for the entire data set. Splice junctions are filtered based
on their overall occurrence – a putative junction is considered in the analysis for all
samples even it has been seen, with adequate evidence, only in a small portion of the
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samples. Pooled read coverage information averaged over all samples is examined,
suggesting transcription start/end sites by recognizing positions with sharp coverage
change. Together with the splice sites of the junctions, these sites are integrated
to determine the precise exon boundaries in the genome. A unified splice graph
is hence obtained by adding connectivity (edges) defined by splice junctions and
retained introns between exons (vertices). An algorithm that utilizes the wavelet
transformation has been developed as well to assist the removal of intergenic noises.
The unified graph is lastly augmented into an Expression-weighted Splice Graph
(ESG) with a weight vector to keep track of the observed read coverage of every exon
and junction in each sample. Therefore, the ESG provides a central reference for the
transcriptome in all samples, and each sample becomes an instance parameterized by
its own expression at the graph components. With this strategy, the reconstruction
algorithm needs to be applied for only once, and any two samples can be compared on
a same structure. More importantly, for transcripts that are lowly expressed in some
samples, they can still be recognized when other samples are leveraged where they are
more abundant. This could benefit the completeness of the transcript reconstruction
and the accuracy of the differential analysis.
With the ESG available, all possible ways that the exonic sequences of a gene
can get transcribed have been depicted. Every graph path representing a possible
transcript: the start/end vertex indicates the transcription start/termination site,
and the graph edges through which vertices in the path are traversed identify the exon
composition of the transcript. However, directly retrieving full-length transcripts
often typically rely on heuristics [Trapnell et al., 2010b, Li et al., 2011b] to enforce
111
shrinkage on the resulting transcript set. Alternatively, we break down the complexity
of the ESG iteratively into single-entry single-exit closed subgraphs, the alternative
splicing modules (ASMs) [Hu et al., 2012]. This decomposition approach is especially
advantageous in large-scale analysis in which transcript-based models are quickly
overwhelmed by many heterogeneous samples. For every sample, the abundance of
each alternative splicing path is inferred based on the expression of the exons and
junctions within and surrounding the corresponding ASM.
The resulting profiles of splicing isoforms in each sample enable the comparison of
the transcription patterns between subsets of samples, such as normal versus tumor
and across tumor subtypes. In addition to the two-group comparison statistic, we
have defined a multi-group test statistic for differential transcription of each ASM
on the basis of Jensen-Shannon divergence. Analogous to the F-statistic, this test
statistic tests the null hypothesis in which all groups have the same splicing profile on
the ASM. A permutation test is then carried out to derive the null distribution of the
test statistic for all ASMs across the whole genome. The deviation of the observed
value of every ASM from the null distribution is then used as the evidence of differen-
tial transcription. Significant differences are selected according to the estimated false
discovery rate (FDR) [Hu et al., 2012]. For significant alterations, pairwise differ-
ences are further evaluated and tested between subtype groups to search for alterna-
tive splicing variants that have consistent divergence. This procedure will highlight
differential splicing events, the alternative splicing events that exhibit significantly
different splicing ratios between different samples or between different subtypes.
Preprocessing. The goal of the preprocessing step is to condense the raw align-
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ment files into a much succinct format that is both effective and efficient for down-
stream analysis or reanalysis. In order to address this, we introduce a preprocessing
step to summarize the raw data with less records, in a format that simplifies the com-
putation of read coverage. This step is done by splitting a read alignment into exonic
segments that represent continuous sequences covered by the reads and splice junc-
tions that connect the exonic segments. Same entries, such as same splice junctions
and exonic segments that cover a same short exon, can be merged into one entry,
associated with the count of its presence. The splitting and counting job for each
sample can be performed in a distributed fashion, then the count tables are combined
for the entire dataset using a linear-time merge sort-like algorithm. This strategy can
minimize the data transfer and storage for analysis, and can easily accommodate new
samples.
Construct the unified ESG. This pipeline utilizes a joint analysis model that
summarizes all samples with a single graph, which can leverage information from all
samples. The splice graph depicts the possible ways the exonic sequences of a gene
can get transcribed. Every graph path representing a transcript, the start/end vertex
indicates the transcription start/termination site, and the graph edges through which
vertices in the path are traversed identify the exon composition of the transcript.
Further, the expression of the transcript is reflected by the number of reads sam-
pled on each exon. The expression information is represented by the weights in the
splice graph. In particular, the vertex weight represents the averaged read coverage
on an exon, whereas the edge weight represents the number of spanning reads of a
splice junction.
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Alternative splicing events discovery. The alternative exonic events can be
identified through the decomposition of the ESG into ASMs (alternative splicing
modules). An ASM is defined as a single-entry and single-exit subgraph of the splice
graph. The entry node is the only exonic unit where transcripts can flow into the
ASM; similarly, the exit node is the only node where transcripts leave the ASM.
Transcripts diverge into more than one isoforms by following different paths in the
ASM before reconvening at the exit node. The decomposition of an ESG follows a
3-step process [Hu et al., 2012] which allows an iterative identification of all ASMs
in the gene. Step 1: calculate the immediate pre/post dominators of every vertex
of the ESG. Step 2: discover ASM whose entry or exist are vertices with out-degree
or in-degree are more than 1. Step 3: discover nested ASMs where we iteratively
identify nested ASMs within existing ones until no new ASMs can be found in Step
2.
Normalization across samples. The estimated expression of an alternative
transcription path is determined by both its proportion in the transcriptome of the
sample and the sampling depth of the RNA-seq experiment for this particular sample.
Looking at the absolute expression levels of the alternative paths in an ASM, first the
estimated expression levels should be adjusted in order to account for the variation of
sampling depth among samples in the data set. We normalize the RNA-seq dataset
by normalizing the total number of reads sequenced in each sample, which measures
the sampling depth of a sample. For datasets with less heterogeneity, normalization
techniques such as upper-quartile normalization [Bullard et al., 2010] and median
normalization may also be applied, under the assumption that the genes in the specific
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quartiles have the same median expression level in different samples.
Statistical test of differential splicing between multiple sample groups.
Tumors have traditionally been classified into groups according to origins and sub-
types. The different patients and subtypes may reflect different mixtures of cells and
possibly different cancer mechanisms. Here we focus on the question whether there
are consistent differences in isoform utilization between groups.
Let q̄1, q̄2, · · · , q̄k denote the mean distributions of the k sample groups. Let q̄·
denote the grand mean distribution, the averaged mean distribution over all samples
in all groups,
q̄· =
∑k
j=1 nj · q̄j∑k
j=1 nj
. (5.1)
The hypotheses being tested for the k-group differential transcription are then
Null the mean path distributions of the k groups are all the same, q̄· = q̄1 = q̄2 =
· · · = q̄k;
Alternative there exist at least two groups whose mean path distributions are not
the same, ∃i 6= j, q̄i 6= q̄j.
The test statistic of differential transcription on ASM ∆ for k > 2 groups is
changed to
x∆ =
∑k
j=1 nj · JSD(q̄j||q̄·)
k − 1
(5.2)
and
s∆ =
∑k
j=1
∑nj
h=1 JSD(q
h
j ||q̄j)∑k
j=1 nj − k
. (5.3)
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The relative difference in transcription of the ASM ∆ is still measured by the
ratio of the difference among group means x∆ against the within-group variance s∆
d∆ =
x∆
s∆ + σ∆
. (5.4)
5.3.2 Experiment results
Landscape of alternative splicings in BRCA data. We have analyzed 819
RNA-seq samples from the TCGA breast cancer study (BRCA), including 728 tumor
samples and 91 normal samples. The tumor samples are from five molecular subtypes
of breast cancer including Luminal A, Luminal B, Basal-like, HEr2-enriched and
Normal-like, and the normal samples are from two molecular subtypes Normal and
Luminal A. The different patients and subtypes may reflect different mixtures of cells
and possibly different cancer mechanisms. The original read alignments were first
filtered to remove unannotated splice junctions found present (at least 10 spanning
reads) in less than 5% of the data set (40 samples). A total of 237,823 junctions were
kept out of the 1,153,635 raw junctions.
Determination of alternative splicing events.
It has been demonstrated that as many as 95% of all multi-exon genes are alterna-
tively spliced during cell development, differentiation and diseases [Pan et al., 2008b,
Wang et al., 2008b]. The mechanisms of the inclusion or exclusion of exons not only
contributes to the biodiversity of proteins but is also considered as the implication
of human genetic disorders, especially the development of cancer. A procedure has
been designed to automatically categorize ASMs. All pairs of alternative paths in
an ASM are organized into a priority queue [Cormen et al., 2001], with the most
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Figure 5.10: Alternative splicing events category plot on the entire TCGA breast
cancer dataset.
abundant pair (sum of the abundance of the two paths in the pair) always examined
first. The algorithm tries to match the pair, in the order of the queue, to one of
the pre-defined basic alternative splicing models: skipped exon, mutually exclusive,
retained intron, alternative splice site, alternative 5 or 3 end. The process will ter-
minate when a match for a pair is found. If no basic model could fit, we describe the
pair as “combined model”.
In practice, quite many ASMs manifest a combination of multiple basic models,
such as skipped exon and alternative splice site. Therefore, the priority queue is
designed to suggest the dominant pattern that explains the majority of the expres-
sion within the specified genomic region. A total of 15,721 ASMs were discovered
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and 7,309 of them involved novel junctions. Though many (¿5,000) events exhib-
ited complex splicing models with more than two alternative isoforms, we were able
to categorize the pattern with dominant expression and, consistent with previous
findings [Eswaran et al., 2013], observed that exon skipping was the most common
pattern with 7,030 occurrences, followed by 4,990 alternative splice sites, 2,907 al-
ternative 5/3 transcription sites and 685 retained introns (Figure 5.10). Meanwhile,
approximate 1/3 to 1/2 of ASMs are significantly differentiated for each category.
This result illustrates that there is no bias towards any specific ASM category in the
differential analysis.
Inter- and intra-subtype transcription patterns.
Controlled by an FDR < 0.01, the pipeline reported 7,262 differentially spliced
loci from 5,442 genes, including 3,626 novel junctions. Focusing on the tumor samples
only, the pipeline reported 4,293 differentially spliced loci from 3,510 genes under the
same FDR, including 2,180 novel junctions. The heatmap in Figure 5.11 plots the
expression of the 50 most differentially spliced genes, represented by their most variate
alternative path. The normal samples generally exhibit large contrast from tumor
samples, but also form two clusters. Partial normal samples, together with normal
Luminal A samples, constitute a relatively distinct cohort from rest samples (leftmost
columns). The remaining normal samples show similarity with a group of Luminal
A samples. The Basal samples and the Luminal samples show large contrast. The
majority of HEr2 samples exhibit concordance, whereas Luminal A and Luminal B
samples tend to be more heterogeneous.
Subtype-specific regulation of alternative isoforms. The expression of
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Figure 5.11: Heatmap of top 50 most differentially transcribed ASMs (represented by
most divergent path) on the entire TCGA breast cancer dataset. The corresponding
gene symbols are labeled on the right.
Figure 5.12: Exon map of gene CD44.
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Figure 5.13: Two variants of gene KRAS.
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Figure 5.14: log 10 coverage of gene ErbB3.
CD44 isoforms have been suggested as markers of epithelial cancer stem cells. Its stan-
dard isoform, CD44s, skips all variant exons between exon 5 and 15 (Figure 5.12).
High expression of CDD44s has been reported to be associated with strong HEr2
staining and a subgroup of basal-like tumors. Alternative isoforms have been an-
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notated by retaining different sets of variant exons. In particular, previous study
suggested the correlation of CD44v2-v10, the isoform retaining all variant exons,
with low proliferation and Luminal A subtype. In our analysis (Figure 5.15), we
confirmed higher percentage of CD44v2-v10 in Luminal A group (P = 9.854e − 10)
and, as a comparison, an increased abundance of CD44s in HEr2 and Basal groups
(P = 8.183e− 14).
Gene KRAS is a frequently mutated oncogene related to many types of cancer
and KRAS mutations are often associated with a poor overall survival. Two variants
are formed by an exon-skipping event and Variant I is known as a negative regulator
of mutant KRAS alleles (Figure 5.16). In KRAS, we detected the exon skipping
event that constitute the two known variants of this gene. The retaining path that
keeps exon 4a corresponds to variant I, a variant known as a negative regulator of
mutant KRAS alleles. We found over-expression of variant I in HEr2 and Luminal
samples (P < 2.2e − 16), but not Basal and Normal-like tumors. This pattern may
be associated with different mutation rates in breast cancer subtypes (Figure 5.16).
Potential modulator involving novel splice variant. The comprehensive
analysis on cancer transcriptomes has also highlighted several novel alternative splic-
ing events with subtype-specific transcription. An unannotated mutual exclusive
event in gene CYFIP1 exhibited isoform switching in Luminal A and Luminal B as
compared to Basal-like and HER2-enriched. Figure 5.17(a) displays the structure
of the novel mutual exclusive event in one of Luminal B tumor sample. A unique
exon (the second one) forms one alternative path that is missing from tumor Normal
sample. This path is also shown as path p1 in Figure 5.17(b). We can see clearly
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that p1 is more abundant in Luminal A and Luminal B samples than all the other
samples.
Differential gene expression. In addition to detecting transcription level dif-
ferences, The DiffSplice-based pipeline also estimates read coverage of every gene.
Unlike gene level methods which directly counts the number of reads falling in one
gene or averages the read coverage over the entire gene, our method propagates
abundance information of splicing variants to the estimation of gene expression and
therefore is unbiased toward different transcript length. For example, we detected
up-regulation of gene ErbB3 in all tumor subtypes as compared to normal groups.
In line with the previously reported correlation between ErbB3 expression and lu-
minal breast cancer growth (ErbB3 downregulation enhances luminal breast tumor
response to antiestrogens), the fold changes of Luminal B and Luminal A groups were
2.80 and 1.75, respectively as compared to double normal group. Moreover, we found
over-expression of ErbB3 in Basal (fold change=1.89) and HEr2 (fold change=2.13)
groups, suggesting its correlation with all breast cancer subtypes (Figure 5.14).
5.4 Discussion
With the rapid development of sequencing technology, more and more samples are
being sequenced by researchers seeking for a comprehensive understanding of cell
development or diseases. But how do we extract salient information from the massive
dataset remains a challenging problem, for example, can we find biomarkers from
hundreds of cancer transcriptomes? In this chapter, we review the problems with
analyzing the large-scale RNA-seq dataset and systematically investigate the existing
122
pipelines using TCGA breast cancer dataset which consists of 819 RNA-seq samples.
Given the limitations of the previous methods, we have developed a comparative
model aiming at a unified analysis of the entire dataset. To our best knowledge, this
is the first approach dedicated to large scale transcriptome analysis. Its contribution
is three-fold. First, it’s highly scalable. By preprocessing the high volume data first, it
greatly condenses the raw data into a much succinct format which is supper effective
and efficient for downstream analysis or reanalysis. Moreover, this process is easy
to extend to distributed systems as well as deploy on cloud platform. Second, the
unified framework is more accurate. It makes use of the power of full dataset which
eliminates the biases introduced in the filtering step when merging all sample results
together. Last but not least, it has a procedure automatically detect the alternative
splicing category of the potential splicing signatures which manifests a visual idea of
mechanisms of alternative exon selection.
Copyright c© Yan Huang, 2015.
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(b)
Figure 5.15: Gene CD44. (a) Boxplot showing the ASM path abundance distribution
of all samples grouped by the subtype: CD44v2-v10 (orange) and CD44s (blue). (b)
log2 expression ratio of CD44v2-v10 / CD44s.
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Figure 5.16: Gene KRAS. (a) Boxplot showing the ASM path abundance distribution
of all samples grouped by the subtype: variant II (orange) and variant I (blue). (b)
log2 expression ratio of variant II / variant I.
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Figure 5.17: Gene CYFIP1. (a) Sashimi plot of the mutual exclusive event structure
in gene CYFIP1. The upper plot shows a sample from tumor Normal and the bottom
plot shows a sample from tumor Luminal B. (b) Boxplot showing the ASM path
abundance distribution of all samples grouped by the subtype.
126
Chapter 6 Conclusion
This dissertation has presented a series of methods for a comprehensive analysis of
mRNA transcriptome using RNA-seq data, including accurate abundance estimation
of the annotated transcripts, simultaneous reconstruction and quantification of the
novel genes and isoforms, and unified analysis on large-scale datasets. With these
approaches, we are able to study the steady state of the existing mRNA transcript
database as well as detect genes or isoforms that are not previously catalogued. Most
importantly, an ab initio pipeline has been developed which takes advantage of the
advancement of sequencing technology and performs transcriptome analysis both ef-
ficiently and effectively on massive RNA-seq data.
Precise transcript quantification determines the steady state levels of alterna-
tive transcripts within a sample, enabling the detection of differences in the expres-
sion of alternative transcripts under different conditions. Its application in detect-
ing biomarkers between diseased and normal tissues can greatly impact biomedi-
cal research. The challenges of solving this problem reside in three aspects: first,
short reads often do not uniquely identify the transcript isoforms from which they
were sampled, leading to a unidentifiable model of transcript quantification; second,
RNA-seq reads sampled from the transcriptome exhibit unknown position-specific
and sequence-specific biases; lastly, not all of reference transcripts are likely to be
significantly expressed in a given tissue type or condition. The first method has been
developed aiming at resolving all these difficulties using a generalized linear model.
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A novel feature named MultiSplice which summarizes reads spanning multiple splice
junctions was incorporated as additional response variables to ameliorate identifiabil-
ity. Bias parameters were also embedded into the coefficients of the linear model to
adjust for various sampling biases. LASSO was further adopted for solving the linear
system in order to infer an accurate set of dominantly expressed transcripts.
Simply studying the existing reference transcript database is not enough. Novel
mRNA transcripts are often observed in various transcriptome, especially in diseased
samples. For example, aberrant alternative splicing in cancer cells may lead to uncat-
alogued isoforms that could be potential biomarkers. To fully enable the translation
from raw sequencing data to clinical insights, the core part of this dissertation fo-
cus on an ab initio framework to reconstruct the identities and quantities of the
full-length gene isoforms residing in original cells, through inference based on the se-
quenced partial, noisy samples. We have developed a novel algorithm named Astroid
that simultaneously infers isoforms together with their abundance, by assembling all
observed reads into a set of chains that maximizes their joint probability. The ob-
served data is modeled as a flow network, with every read being a vertex. Two reads
are connected in the graph if they can potentially form a fraction of an isoform. The
edges are further weighted by the likelihood of the linkage, evaluated according to the
distribution of the distance. We solve for a best set of isoforms by finding a maximum
likelihood set of non-overlapping source-to-sink paths, chains, which thread through
all vertices. This maximization problem is then converted into a minimum-cost flow
problem on the flow network. Lastly, we introduce a set of rules that clusters homoge-
neous vertices and edges and compresses the flow network. A compression parameter
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is defined to leverage the time and space complexity required by the flow network and
the model accuracy. Simulation studies and experimental benchmark on MAQC data
set have demonstrated significantly improved sensitivity and specificity of Astroid in
gene isoform reconstruction, as compared to 4 other state-of-the-art approaches. The
unique design of Astroid that models a read-level network also enabled high accuracy
in isoform abundance estimation. Furthermore, we have demonstrated the efficacy of
the proposed compression method, which can successfully boost the speed and reduce
memory usage by several magnitudes, while maintaining a comparable performance.
Empowered by the advancement of sequencing technologies, the role of sequencing
data in any biomedical research/application is becoming more and more prominent.
How to dig out treasures from the “big RNA-seq data” generated from a large num-
ber of samples is quite challenging. Besides effectiveness, scalability are now more
emphasized in the evaluation of computational approaches. A comprehensive pipeline
which extends our previous work DiffSplice is presented dedicated to large-scale tran-
scriptome analysis. It has several contributions. First, since the complexity of data
my increase exponentially with the sample size, the existing pipelines usually rely
on known gene/isoform database by ignoring the possibility of uncatalogued tran-
scripts in each sample. Our method, on the other hand, doesn’t require any prior
knowledge of reference transcripts, allowing the detection of novel genes and isoforms
effectively. Second, our model directly takes input of the RNA-seq read alignments
from all samples and constructs the unified genome-wide expression-weighted splice
graph (ESG) to summarize the expression and splicing information on the genome in
the given dataset. Downstream analysis is then performed on the unified ESG. While
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other approaches all adopt per sample analysis first and then merge the results where
great noises arise given the discrepancy among different samples. Moreover, further
filtering may also lead to loss of information. Last but not least, our method itera-
tively decomposes the ESG into a set of ASMs: the regions where alternative splicing
happens. These regions can then be further tested for potential splicing signatures
between different group of samples. This procedure avoids the reconstruction and
quantification of full-length transcripts which itself as demonstrated before is quite
difficult especially consider the scale of the data.
All software packages of the methods described in this dissertation are open-
source, released and maintained at http://www.netlab.uky.edu/p/bioinfo/ and
freely available to the research community.
Nowadays, the sample size is continuously increasing. For example, there were
510 samples when the first systematic investigation of TCGA breast cancer project
was published in 2012 [Network, 2012], but now we are looking at totally 819 samples
and the number is still climbing. More samples promise more power but also ex-
hibit more variance which poses much more difficulty of a both efficient and effective
analysis. The core unit of the extend DiffSplice pipeline handling massive dataset si-
multaneously is the construction of unified ESG which summarizes information from
the entire dataset, filters out false signals and depicts all exonic segments and splice
junctions on the genome. This process is also the foundation for Astroid since read
alignments are connected into transcript copies guided by the possible path on the
splice graph. Therefore, how to build an accurate splice graph with minimum false
signals is very important, especially for large-scale dataset. Besides basic filtering
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of spurious based solely on read count support, more sophisticated strategies should
be investigated. One feasible approach would be use some collective statistics to
guide the splice junction filtering, such as distribution of support in all samples, to-
gether with annotated gene models and find a reasonable way to select unannotated
junctions that are probably real. More specially, a predicative model could be es-
tablished as a binary classifier. Moreover, some complex cases are ignored during
the construction of ESG, such as reads derived from total RNA-seq (where intronic
reads dominate the sequencing library due to random priming instead of oligo-dT
enrichment) and also fusion genes / chimeric transcripts, where reads / mate pairs
map to different genes due to chromosomal rearrangements. However, these aberrant
reads usually represent abnormal transcriptome activities. For example, fusion genes
plays an important role in tumorgenesis because they can produce much more active
abnormal proteins than non-fusion genes. Therefore, we could integrate this kind of
information like fusion and extend this pipeline for a more complete transcriptomic
profile.
Copyright c© Yan Huang, 2015.
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